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“Our goal should be to understand our differences.” 
James D. Watson 
 
  
ABSTRACT 
Asthma and allergy are the most common chronic childhood diseases. Their occurrences are 
influenced by both genetic and environmental factors, although the underlying mechanisms 
are not fully understood.  
The overall aim of this thesis was to study the role of genetic polymorphisms and epigenetic 
alterations in interaction with environmental factors related to childhood respiratory and 
allergic disease. Epidemiological data from the Swedish prospective birth cohort BAMSE 
and other European and North American cohorts were analyzed, in addition to material from 
functional studies and bioinformatics resources. 
Study I included 14,495 children from five European and one North American birth cohorts. 
Early mold exposure at home was associated with increased risk of early wheezing and 
childhood nasal symptoms. Effect modification by the functional GSTP1 single nucleotide 
polymorphism (SNP) Ile105Val could not be confirmed. However, stratification by genotype 
revealed statistically significant associations between mold exposure and childhood nasal 
symptoms confined to Ile/Ile carriers. 
The previously identified asthma-associated gene NPSR1 was investigated in Study II. 
Differential DNA methylation in the NPSR1 promoter region was associated with adult 
severe asthma (CpG site 5) (n=171), and childhood allergic asthma (CpG sites 1 and 4) 
(n=546) but not with non-allergic asthma. Current and former smoking in adults was 
associated with increased DNA methylation (CpG sites 1 and 8) as compared with never-
smoking. The season of blood sampling was associated with differential methylation at CpG 
site 5, whereas no such associations were seen for season of birth. 
Study III aimed to identify genetic regions of importance in the association between traffic 
air pollution exposure (NO2) and childhood asthma, with further functional analyses of 
identified loci. A genome-wide interaction study (GWIS) in 1,534 children from three 
European birth cohorts, with look-up of SNPs with interaction p < 1x10-4 in two North 
American cohorts (n = 1,602 and 186, respectively), revealed significant interaction for eight 
SNPs in four different loci. Two of the identified genes, ADCY2 and DLG2, have previously 
been associated with lung function and COPD. Functional follow-up showed an inverse 
association between NO2 exposure at birth and DNA methylation in one CpG site of DLG2 in 
8-year-olds. Short-term diesel exposure in adults revealed inverse associations with DLG2 
DNA methylation in eight additional CpG sites and positive associations in two CpG sites. 
One of the SNPs identified in the look-up evaluation, rs686237, was found to strongly 
influence B4GALT5 expression in adult lung tissue. Interaction between rs686237 and NO2 
exposure at birth in relation to B4GALT5 gene expression was detected in blood from 16-
year-olds. 
Associations between dietary antioxidant intake and development of asthma and allergic 
disease were investigated in 2,359 children in Study IV. An inverse association was 
identified for new onset sensitization to inhalant allergens between 8 and 16 years of age. The 
association was stronger among children exposed to low levels of current traffic air pollution 
(NOx), with a significant interaction between antioxidant intake and current NOx. 
In conclusion, the results in this thesis imply that genetic variants can influence associations 
between environmental exposures, such as mold and traffic air pollution, and asthma and 
allergic disease. Interactions between environmental factors may also influence disease 
development. Further, there seems to be a link between environmental exposures and 
epigenetic as well as transcriptomic events, which warrant further investiogations.  
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1 INTRODUCTION 
Asthma and allergy in children are complex diseases meaning that both the individual genetic 
setup and environmental factors contribute to determining disease incidence and persistence. 
Parental allergic disease is the primary risk factor for disease development in children. 
Heritability of allergic disease (asthma, rhinitis and eczema) has been estimated to 50-80%1, 2. 
The importance of environmental factors may be reflected by the fact that disease prevalence 
has increased in the last 50 years3, 4, most likely due to a rapid change in the exposure to 
environmental factors. When studying complex diseases like asthma or allergy, one has to 
consider that some individuals could be more susceptible to certain environmental exposures 
due to their genetic make-up. 
This thesis aimed to explore the complexity of allergic disease by studying interactions 
between environmental and genetic factors using different epidemiological and experimental 
approaches. 
The methods used in genetic epidemiology have developed in parallel with advances in our 
understanding of the human genome. Thanks to new genotyping technologies and the 
organization of large consortia and international collaborations, I have had the possibility to 
investigate gene-environment interactions (GxE) at a genetic, epigenetic and transcriptional 
level within this thesis.  
 2 
2 BACKGROUND 
2.1 RESPIRATORY AND ALLERGIC DISEASES 
The prevalence of asthma and allergic disease has increased during the second half of the last 
century, but seems to have reached a plateau in high income countries3, 4. Around 30-40% of 
the population in the world have some type of allergic disease4. Asthma is the most common 
chronic disease in children5. 
2.1.1 Allergic disease 
Allergic diseases are disorders manifested by an immune response towards normally 
harmless substances in the environment, called allergens. Allergic reactions can be viewed as 
an overreaction of the immune system to these allergens. Allergens are usually proteins that 
exist at low levels in the environment. These can be inhaled from outdoor air, e.g., pollen or 
molds, or from indoor air, e.g., allergens from house dust mites or furred pets. A person can 
also be exposed to allergens through ingestion of foods. Below follows a simplified 
description of the sensitization process and a subsequent asthmatic allergic reaction upon 
inhalation of an allergen.  
2.1.1.1 The sensitization process 
Sensitization refers to production of immunoglobulins (for allergy, mainly immunoglobulin E 
(IgE)) towards allergens6, 7. The first time a person encounters an airborne allergen it will 
pass through the airway epithelium and be taken up by dendritic cells (antigen presenting 
cells). The dendritic cell migrates to the regional lymph node, where it presents the allergen 
to a naïve CD4+ T cell. The naïve T cell is stimulated by the cytokine interleukin 4 (IL4) to 
develop into a Th2 cell. The Th2 cytokines IL4 and IL13 then stimulate B cells to production 
of allergen-specific IgE antibodies. These IgE antibodies can bind to mast cells positioned 
beneath the airway epithelium and to basophils. 
The fate of a naïve T cell depends on which cytokines it is exposed to, the properties of the 
antigen, the dose and the route of exposure as well as the host genotype and co-exposure with 
other agents that can enhance the sensitization process. Development of a naïve T cell into a 
Th1 cell will lead to production of interferon gamma (IFNɣ) and inhibition of IgE production. 
2.1.1.2 Allergic reaction  
A person can be sensitized without showing clinical symptoms after additional exposure to 
the allergen. However, the probability of clinical symptoms increases with increased levels of 
IgE antibodies present. A person who does show symptoms after additional inhalation of the 
allergen is said to be allergic. Re-exposure to the allergen triggers an immediate allergic 
reaction. Allergen binding to the allergen-specific IgE on a mast cell triggers mast cell 
activation7. The mast cell will then release inflammatory mediators such as histamine, 
causing increased mucous production, bronchoconstriction, vasodilation and increased 
vascular permeability with edema in the lung. 
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This rapid response is followed by a slower reaction with sustained inflammation by 
activation of transcription factors and recruitment and activation of several cell types from the 
blood stream, including Th2 cells, eosinophils, and basophils, contributing to a late-phase 
reaction. This occurs hours after the allergen exposure and is characterized by airway 
narrowing and mucus hypersecretion. Prolonged or repetitive exposure to the allergen can 
subsequently evolve into a chronic inflammation state characterized by presence of 
leucocytes, more mast cells with large amounts of IgE bound and structural changes with 
increased smooth muscle cells, scar tissue, mucous production and epithelial barrier 
dysfunction. 
Activation of mast cells beneath the airway epithelium will result in allergic asthma, whereas 
activation of mast cells beneath the nasal epithelium is associated with allergic rhinitis. 
2.1.1.3 Allergic sensitization 
Investigation of allergic sensitization at the clinic as well as in epidemiological studies can be 
performed through a skin prick test or by measuring the levels of allergen-specific IgE 
antibodies in the blood. Up to 40% of the world’s population are sensitized to some type of 
allergen4. Among children, the prevalence has been reported to increase by age, and the 
prevalence in school children has been reported to be up to 50%4, 8, 9. In Swedish children, 
sensitization to birch pollen and furred animals is most common8, 9, whereas sensitization to 
molds, house dust mite or cockroaches is common in other countries4. 
2.1.2 Asthma 
Asthma is a heterogeneous disease characterized by chronic airway inflammation with 
structural changes of the airway epithelium such as increased smooth muscle cells, mucus 
hypersecretion and narrowing of the airways. It is associated with hyper-responsiveness and 
airflow obstruction resulting in shortness of breath, a wheezing sound at breathing, and 
cough10. In mild asthmatics, the exacerbations can be triggered by respiratory tract infections, 
physical activity, cold air or exposures such as tobacco smoke or allergens4. Severe 
asthmatics have symptoms that are more continuous despite treatment. 
Clinically, asthma is diagnosed based on patient history and symptoms of wheeze, heavy 
breathing, and cough. Obstructive symptoms are common among young children, especially 
in combination with airway infections, making it harder to diagnose true asthma in younger 
ages. Epidemiologists often use standardized questionnaires to assess asthma. Parental-
reported doctor’s diagnosis of asthma, current symptoms of wheeze, and the use of asthma 
medication can be used to define previous or current disease. 
2.1.2.1 Lung function 
Lung function tests can be performed to evaluate a clinical diagnosis, such as asthma or 
chronic obstructive pulmonary disease (COPD). Spirometry measures the volume of air a 
person can breathe in or out and the flow. Forced vital capacity (FVC) is the total volume of 
air exhaled. Forced expiratory volume in one second (FEV1) is the amount of air exhaled 
 4 
during the first second and this spirometry parameter is a commonly used measure of lung 
function. The ratio of FEV1 on FVC (FEV1/FVC) gives an indication of airway obstruction 
that is characteristic of asthma and COPD. 
2.1.3 Rhinitis 
The clinical characteristics of allergic as well as non-allergic rhinitis include sneezing, 
itching, and a runny, blocked nose, due to inflammation in the nasal epithelium11. In 
sensitized patients, allergic conjunctivitis commonly co-occurs with allergic rhinitis and is 
characterized by itchy, red and watery eyes, and sometimes also swelling around the eyes. 
Allergic rhinitis is most often triggered by allergen exposure, leading to an IgE-mediated 
inflammation of the nasal mucosa 4. 
A clinical history of symptoms and exacerbating factors supported by examination of the 
nose is used to diagnose rhinitis, and IgE testing for classification of allergic vs. non-allergic 
rhinitis. In epidemiological studies, questionnaires regarding nasal symptoms without 
simultaneous common cold (and IgE tests) are used to assess rhinitis. 
 
2.2 OXIDATIVE STRESS AND INFLAMMATION 
The exact biological mechanisms and individual susceptibility for asthma and allergic 
diseases are not fully understood, but antioxidant and inflammatory responses have been 
suggested to be among the key pathways12. The inflammatory response and release of 
reactive oxygen species (ROS), by bronchial epithelial cells as well as by eosinophils and 
neutrophils, have been found to be increased in asthmatics as compared with non-
asthmatics13, 14. 
Normally, there is a balance in the body between oxidant and antioxidant events. Oxidative 
stress can be simplified as a shift in the balance towards more oxidative events (Figure 2.1). 
Oxidative stress and acute inflammation are natural defense mechanisms that protect the body 
from harmful events.  
At low levels of oxidative stress, the transcription factor nuclear factor E2-related factor 2 
(Nrf2) is activated and induces expression of more than 200 genes, such as the antioxidant 
enzymes catalase, superoxide dismutase, heme-oxygenase-1 and glutathione s-transferases 
(GSTs) which can detoxify free radicals15. These are endogenous antioxidants. At higher 
levels of oxidative stress, pro-inflammatory cytokines and chemokines become activated, 
which can lead to increased airway and systemic inflammation16.  
Diet can contribute with exogenous antioxidants, such as vitamin C, vitamin E, carotenoids 
and polyphenols, but there are many more antioxidants present in our diet, which can interact 
with each other in synergistic or antagonistic manners17. Dietary antioxidants are suggested to 
improve endogenous antioxidant defenses and lower oxidative stress levels. Diminished 
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antioxidant protection or induction of ROS from environmental exposures, such as air 
pollution, might induce oxidative stress and inflammatory responses. 
 
 
Figure 2.1 Increase in ROS levels leads to an oxidant antioxidant imbalance, initiation of inflammation and 
oxidative stress-induced tissue damage. 
 
2.3 ENVIRONMENTAL FACTORS 
Changes in environmental and lifestyle exposures are probable explanations for the increased 
prevalence of asthma and allergic diseases. Both indoor and outdoor environmental factors 
have been reported to influence the risk of disease, as have dietary habits18, 19, and conditions 
like overweight and obesity20.  
In 1989, Strachan reported associations between hay fever and family size as well as the 
number of older siblings in the household21. This “hygiene hypothesis” suggested that lack of 
early childhood exposure to infectious agents increases the risk of allergic diseases, as a Th1 
cell response to bacteria and viruses would suppress the Th2 cell response. However, it has 
later been shown that certain bacterial and viral infections can increase the risk of asthma22. It 
is now believed that a diverse exposure to microbes in early childhood could contribute to 
protection against both asthma and allergic disease, although timing and exact species remain 
to be clarified 23. Growing up on a traditional farm protects against asthma and allergic 
diseases24. 
The airway epithelium is the first line of response to inhaled environmental exposures. An 
intact epithelium barrier will reduce allergen passage, protect against infections and enhance 
the interaction with the innate immune system23. Environmental exposures, such as smoking, 
air pollution or allergens may decrease epithelial barrier function. Several asthma- and 
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allergy-related genes, such as cytokines, interleukins and toll-like receptors, are expressed in 
epithelial cells and contribute to barrier function. 
Children are considered particularly susceptible to environmental exposures because of their 
immature immune function, growth and development, and the fact that they eat, drink and 
breathe more in relation to their body weight than adults do. Genetic predisposition, parental 
allergic disease, second hand tobacco smoke exposure and prematurity are some of the more 
established risk factors for childhood asthma and allergic disease25.  
The timing of exposure, during critical periods of organ and tissue development, seems to be 
of importance for health outcomes later in life. For example, pregnancy and early life 
exposure to smoking increases the risk of asthma in children26, 27. Similarly, pregnancy or 
early life exposure to traffic air pollution may have lasting impacts on respiratory outcomes 
later in life28, 29. However, since asthma development is a dynamic process throughout 
childhood, it is also of interest to study exposures later in childhood in relation to disease8, 30-
32. 
2.3.1 Indoor mold and dampness 
Indoor mold and dampness is a major global problem and an important environmental risk 
factor for public health33. The estimated prevalence of dampness in households ranges from 
10-50% worldwide, and at least 20% of households in Europe, Canada and the Unites States 
have reported signs of dampness34.  
Occurrence depends on climate, air humidity, construction and ventilation of the building as 
well as the occupant’s behavior. Moist indoor conditions allow microorganisms to flourish, 
resulting in exposure to numerous microbial agents such as spores, cell fragments containing 
toxins, inflammatory substances and allergens35. These agents have been shown to act as 
irritants, are immunostimulatory and induce inflammatory responses34.  
There are no recommended guideline values for contamination with microorganisms due to a 
lack of valid quantitative exposure assessment methods. The recommendation today is simply 
to prevent or remediate indoor mold and dampness34. 
Self-reported visible mold or dampness in the home has shown associations with respiratory 
symptoms, respiratory infections, asthma exacerbations, new onset asthma and rhinitis in 
both children and adults34, 36-39. In children specifically, visible indoor mold or dampness has 
been associated with respiratory outcomes such as cough, wheeze, asthma, asthma 
exacerbations and allergic rhinitis34, 37, 40. There are a limited number of studies looking at 
interactions between mold exposure and oxidative-stress-related genes in association with 
allergic and respiratory outcomes41.   
2.3.2 Traffic-related air pollution 
Outdoor and indoor air pollution constitute together major environmental risk to health, and 
outdoor air pollution has been estimated to cause 3 million premature deaths annually 
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worldwide42. Outdoor air pollution levels are increasing globally and it has been concluded 
that 92% of the world population lives in places that exceed the World Health Organization 
(WHO) air quality guidelines42. 
Air pollution constitutes a complex mixture of compounds with different chemical and 
biological properties. Their relative concentrations depend on the source and meteorological 
and geographical conditions.  
The components of ambient (outdoor) air pollution are particulate matter (PM), a complex 
mixture of small particles and liquid droplets, gases such as ozone, nitrogen oxides (NOx) and 
carbon monoxide, as well as vapors, such as volatile organic carbons43. PM10 (particles with 
an aerodynamic diameter less than 10 µm) can reach the lower airways upon inhalation and 
include coarse particles (in the size range of 2.5 to 10 µm) and fine particles (less than 2.5 µm 
in diameter (PM2.5)). Ultrafine particles (particles smaller than 0.1 µm in diameter) are 
proposed to pass the alveolar wall and reach the circulatory system. NOx comprise nitrogen 
oxide (NO) and nitrogen dioxide (NO2). When NO is emitted into the air, it interacts with 
ozone and oxygen and forms NO2. 
Combustion of fossil fuel is the major process that causes air pollutants. Motor vehicles, 
aircraft and boat traffic as well as industry, power plants and household heating are 
contributing sources43. For proximity reasons, emissions from road traffic are of major 
interest to study in relation to human health. NOx comes primarily from road traffic exhaust. 
PM10 relates to road dust originating from mechanical wear of breaks, clutches and tires, as 
well as road wear by studded tires, and sanding and salting of roads in wintertime. NO2 is the 
most common human-generated form of NOx in the atmosphere, and the concentrations are 
strongly correlated with other pollutants. Therefore, it is often used as a surrogate for total air 
pollution exposure from road traffic in epidemiological research44. 
Oxidative stress and airway inflammation are mechanisms involved in health effects 
following inhalation of air pollutants45. Gases like NOx have an oxidative effect and particles 
can contain various substances such as acids, organic chemicals, metals, and soil or dust 
particles that act as irritants of the airways when inhaled43, 46. Lung damage can therefore 
occur by direct formation of ROS or indirectly via induction of inflammation caused by 
higher oxidative stress levels. 
According to the European Commission and the Swedish air quality standards, the annual 
mean of ambient air pollution for NO2 and PM10 should not exceed 40 µg/m
3 47, 48. However, 
there is no evidence for a threshold below which adverse effects do not occur44. 
Epidemiological studies have shown associations between a reduced lung function growth in 
children and air pollution at levels below these standards indicating that the current guidelines 
cannot fully protect human health49. Further, such guidelines may not apply to particularly 
susceptible groups. 
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Different methods can be used to estimate individual exposure to air pollution. Short-term 
exposures in relation to health effects can be assessed through e.g., chamber experiments or 
by letting study participants wear measurement equipment. To investigate long-term effects 
in cohort studies some common methods are to use proxies such as traffic density, proximity 
to major roads or measured levels of air pollutants at a nearby monitoring station. Methods to 
estimate further detailed spatial variation in air pollution levels are dispersion modelling 
relying on measured concentrations at monitoring sites, emission databases and dispersion 
modelling or land-use regression (LUR) modelling based on monitoring and linear regression 
modelling of predictor variables. 
Traffic-related air pollution exposure is known to have negative effects on children’s health. 
In particular, associations have been reported between air pollution exposure and lung 
function development in children49-51. Traffic air pollution is also known to cause asthma 
exacerbations and seems to be associated with acute respiratory infections45. Studies have 
shown an association between traffic air pollution and the development of childhood 
asthma46, 52-54. Two meta-analyses reported that early life exposure was of importance for 
childhood asthma development, and the magnitude of the association increased with 
increasing age52, 54. Another recent systematic review reported positive asthma associations 
related to black carbon, NO2, PM2.5 and PM10 exposure 
55. The potential mechanisms linking 
air pollution to asthma are, however, not fully understood. Studies of the association between 
air pollution and sensitization have shown inconclusive results53, 56.  
2.3.3 Dietary antioxidants 
In the Nordic Nutrition Recommendations a diet rich in vegetables, fruits, berries, nuts, seeds, 
and wholegrain is recommended, to promote general health through its content of essential 
minerals, vitamins and antioxidants57. A decreased intake of antioxidants (fruits and 
vegetables) and n-3 polyunsaturated fatty acids (from oily fish) and an increase in n-6 
polyunsaturated fatty acids (margarine and vegetable oils) is hypothesized to increase asthma 
and allergic disease in children and adults, as such foods have anti-oxidative and anti-
inflammatory properties19, 58. Dietary antioxidants can decrease oxidative stress by 
scavenging of free radicals, and are required by the antioxidant defense system in the lung to 
inhibit damage by ROS59. 
Maternal diet during pregnancy has been suggested to influence the development of asthma 
and allergic disease in children60-63. Duration of breast-feeding is another hypothesized 
influential factor, although observational studies on breast-feeding have been inconclusive64. 
In addition, there is increasing evidence that the timing of introduction of solid foods 
(particularly allergenic foods, e.g., egg, peanut and fish) to the diet may influence the 
development of allergic disease65. The child’s own diet is also of importance; a low dietary 
intake of antioxidants has been suggested to influence asthma and allergic disease in children. 
However, results have been conflicting and few longitudinal studies have been conducted16, 
25, 66, 67. The child’s diet in school age in relation to disease development in adolescence has 
been less studied.  
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Antioxidant supplementation has shown beneficial effects on lung function decline in relation 
to ozone exposure in asthmatic children with genetic susceptibility to oxidative stress68. 
However, clinical trials have not supported the use of individual supplements for prevention 
or treatment of asthma and allergic disease16. On the other hand, consumption of a balanced 
diet rich in antioxidants has proven favorable in prevention of asthma and allergic disease67, 
69. Most children in Sweden get enough vitamins and minerals through their food. However, 
consumption of fruits and vegetables was only 50% of the recommended consumption of 400 
grams per day according to a nation-wide nutrition survey performed by the Swedish 
National Food Agency among 4-, 8- and 11-year-olds70. 
Measuring dietary intake is challenging for a number of reasons. Assessment can be done 
using open-ended surveys such as dietary recall or records, or by using a food frequency 
questionnaire (FFQ) with pre-specified response categories. Both methods require that the 
child and/or the parent can recall what and how much the child has eaten. FFQs are common 
in epidemiological studies because they are simple, cost-effective and timesaving. 
Biochemical markers can be used as a surrogate for dietary intake by measurements in, e.g., 
blood or urine. However, the values obtained cannot be translated into absolute intake due to 
internal mechanisms such as absorption, metabolism, disease status or homeostatic regulation 
that can affect the measured level71. 
2.3.3.1 The concept of dietary total antioxidant capacity (TAC) 
Total antioxidant capacity (TAC) of diet is considered to be a better estimate than 
investigating intakes of individual antioxidants from diet. TAC serves to assess the 
cumulative action of the antioxidant content in a sample72. TAC is therefore better at 
estimating “real life” antioxidant intake, as thousands of compounds are usually ingested 
simultaneously. Moreover, individual antioxidants, e.g., vitamin C, E, carotenoids, and 
polyphenols, are highly correlated with one another, therefore, focusing on an individual 
antioxidant from foods will not ensure that it is the compound of interest that is truly 
investigated. In addition, there are synergistic effects between compounds which TAC takes 
into account. Thus, TAC is considered superior because it aims to capture the whole 
antioxidant network present in foods, taking the synergistic effects into account. 
2.3.3.2 Disease-related modification of consumption 
Current or previous allergic disease (or parental allergic disease) may cause an individual to 
change their diet. Children may for example avoid some fruit or vegetables due to allergic 
symptoms. This will make it more difficult to investigate the true association between 
exposure and outcome and has to be taken into consideration when studying dietary intake in 
relation to allergic diseases73.  
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2.4 GENETIC FACTORS 
2.4.1 Single nucleotide polymorphisms 
The genetic code is made up of sequences of the four nucleotides cytosine (C), guanine (G), 
adenine (A) and thymine (T). The most commonly studied type of genetic variation is 
differences in individual nucleotides in the deoxyribonucleic acid (DNA), so-called single 
nucleotide polymorphisms (SNPs). If the SNP sits in a regulatory region, it could affect gene 
expression, and if it is located in a coding region, it could alter the function of the gene and 
the gene product (i.e., the protein). Hence, the variant (also called allele) could be associated 
with disease, which is often investigated by studying the difference in frequency of the allele 
between cases and controls.  
Given the importance of the oxidative stress and anti-inflammatory mechanisms, genes in 
these pathways have been highly relevant targets for investigation. Susceptibility of the target 
organ to oxidative injury appears to be dependent on the ability to upregulate protective 
systems and it is likely that genetic variations could modify the effects of environmental 
exposures74. 
2.4.1.1 Glutathione S-transferase pi 1 (GSTP1)  
Glutathione S-transferase pi 1 (GSTP1), located on chromosome 11q13.2, is a candidate gene 
that has been studied in relation to asthma and allergy due to its link to oxidative stress 
mechanisms. GSTP1 codes for a Phase II enzyme, belonging to the GST family of enzymes, 
which becomes activated at low levels of oxidative stress in order to protect against 
electrophiles, oxidative stress and ROS, where the GST transferases catalyze glutathione 
conjunction to detoxify reactive electrophiles75. GSTP1 is the predominant cytosolic GST 
expressed in lung epithelium, which can assist in the reduction of ROS-induced inflammation 
and tissue injury upon inhalation of toxic substances76. 
GSTP1 genotypes have been associated with asthma and allergy77. A meta-analysis of the 
functional SNP GSTP1 Isoleucine105Valine (Ile105Val) in relation to asthma revealed a 
suggestive protective effect of the Val allele, although with large heterogeneity between 
studies78. Further, the GSTP1 Val allele showed a weak positive association with wheezing, 
whereas the association was negative for bronchial hyper-responsiveness, and it was 
concluded that future research should focus on interaction with environmental oxidative 
exposures. Studies do show that GSTP1 genotypes could modify the effects of traffic air 
pollution oxidative environmental exposures in relation to asthma and allergic disease79-84 as 
well as lung function85. Only one study before our study I had investigated GSTP1 in relation 
to mold exposure; it found no interaction between GSTP1 Ile105Val and mold in relation to 
early wheeze in children82. 
2.4.1.2 Tumor necrosis factor (TNF) 
Tumor necrosis factor (TNF), located on chromosome 6p21, encodes a pro-inflammatory 
cytokine and has been suggested to be of importance in several inflammatory disorders86, 87. 
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Several TNF SNPs have been investigated in relation to disease, and in particular, the -
308G/A polymorphism which has been associated with asthma86. Interaction was also found 
between TNF SNPs and early maternal smoking in relation to early childhood wheeze88. In 
addition, interactions between GST, TNF genotypes and traffic air pollution in association 
with sensitization have been reported81. 
2.4.1.3 Neuropeptide S Receptor 1 (NPSR1) 
Neuropeptide S Receptor 1 (NPSR1) (previously named GPR154 or GPRA), located on 
chromosome 7p14.3, belongs to the G protein-coupled receptor family and is activated by 
neuropeptide S (NPS)89. NPSR1 was identified as an asthma candidate gene by positional 
cloning and has been found to be associated with high serum IgE and asthma90. Several 
studies have confirmed these associations91-98, whereas other studies report no association 
between NRSR1 genotypes and asthma or sensitization99, 100. Interaction seen between NPSR1 
genotypes and farming lifestyle in relation to childhood allergy warrants of further 
investigation of this gene in relation to environmental exposure101. 
2.4.1.4 Genome-wide association studies (GWAS) 
Additional genes, other than those suggested from linkage studies or related to certain 
pathways, might be important for disease susceptibility. In the last 15 years, the research field 
has developed from linkage studies and candidate gene approaches, to more hypothesis-free 
(or hypothesis-generating) genome-wide studies, where the whole genome is studied in 
relation to a disease or trait of interest. The human DNA is 99.9% identical between 
individuals; still, our DNA encompasses several million SNPs. These are located in both 
coding or non-coding regions and about 3-5% of the SNPs are estimated to be functional, 
meaning that they may affect the expression or function of genes102. 
In 2001, the Human Genome Project established the first full genome sequence, covering 1.4 
million SNPs of the human genome103. Later, the international HapMap project genotyped 
first 1 million SNPs, and, in the second phase, 3 million SNPs in 270 individuals and 
established linkage disequilibrium (LD) patterns102. LD is the non-random association 
between alleles at different sites on a chromosome. Alleles located close to each other are 
more likely to be inherited together and create patterns of SNPs called haplotypes. These 
haplotype blocks were mapped by the HapMap project. By identifying a set of SNPs, 
researchers can predict the rest of the SNPs in a haplotype using these maps. SNP genotyping 
arrays, so-called GWAS chips, make use of these specific tag SNPs and thereby the number 
of SNPs on a chip can be lowered to about 500,000 common variants and still predict up to 
millions of SNPs by imputation methods. Imputation with a certain reference panel allows 
meta-analysis of data from different genotyping chips, as the same set of SNPs is added to 
each study regardless of the genotyping chip used. The 1000 Genomes Project has now 
sequenced more than 2,000 individuals and characterized 84.7 million SNPs104. The 
establishment of these methods, as well as increased computational power and large 
consortia, have made GWAS analyses a facilitated tool in performing genetic research.  
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In the first GWAS on childhood asthma, variants at the ORMDL sphingolipid biosynthesis 
regulator 3 (ORMDL3) and Gasdermin B (GSDMB) loci were found to be strongly associated 
with asthma in children105, and later in the large-scale GABRIEL consortium, several 
additional loci were discovered106. The association between the 17q21 locus with asthma has 
been replicated consistently107. Variants within the locus have also shown interaction with 
smoking exposure108 and rhinovirus bronchitis109 in relation to early-onset asthma.  
Much hope has also been placed in genome-wide interaction studies (GWISs), where GxE is 
studied in genome-wide data, with the use of more powerful statistical models110-113. 
Individual genes have been studied for GxE81, 84, 88, 114. However, few studies have looked at 
interaction at the genome-wide level and no study has looked at SNPxNO2 in a genome-wide 
manner in relation to asthma in children. 
To be able to identify disease mechanisms, the function of the gene is of particular interest. It 
is also important to understand how the gene is regulated, where and when it is expressed, 
and if there are differences in these patterns between healthy and diseased individuals. 
2.4.2 Epigenetics 
Epigenetic changes are chemical modifications of DNA. The most studied epigenetic 
modification is DNA methylation, where a methyl group is attached to a cytosine that sits 
next to a guanine in the DNA strain, a so-called CpG site. DNA methylation is functionally 
involved in several regulatory mechanisms such as imprinting, X chromosome inactivation 
and silencing of repetitive DNA115. About 40% of the CpG islands are located near the 
promoters of human genes and have been frequent targets for DNA methylation analysis due 
to their functional relevance in gene repression116. However, the relationships between DNA 
methylation and gene regulation have been shown to be more complex.  
The genetic sequence is consistent across cells, although different cell-types may have 
different methylation patterns and therefore it is important to select an appropriate tissue for 
analysis. Also, most tissue samples consist of heterogeneous cell types - a fact which must be 
taken into consideration in analysis of DNA methylation levels117.  
Different methods can be used to study DNA methylation: a targeted locus-specific approach, 
a genome-wide approach or a global methylation approach. The latter provides information 
about total methylated CpG sites in a sample, whereas no information is given about the 
status at individual loci118. Epigenome-wide association studies (EWASs) can be performed 
using high-throughput sequencing or microarrays.  
DNA methyltransferases (DNMTs) are enzymes that add methyl groups to DNA115. Since 
DNMTs are not active in the DNA amplification step, the methyl groups will then be erased 
from their positions. Bisulfite treatment is a commonly used method that selectively changes 
all unmethylated cytosines to uracils (Figure 2.2). When sequenced or genotyped a thymine 
at the position of a CpG site is an indicator of an unmethylated cytosine.  
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Genetic variability within CpG sites and SNPs located more distantly from the CpG site 
could affect DNA methylation. Distantly located SNPs that affect DNA methylation are 
named methylation quantitative trait locus (methQTL). Methylation patterns could also vary 
based on environmental exposure and have therefore become a hypothesized mediator of the 
association between environment and gene function. 
Environmental factors such as maternal smoking and air pollutants linked to asthma may 
induce epigenetic effects, although it is not known whether differential DNA methylation is 
of actual importance in the development of asthma119, 120. Lately, childhood asthma and 
environmental exposure, have been shown to be associated with differential methylation in 
several gene-specific and genome-wide studies121-124, and may also be related to ageing125. 
2.4.3 Transcriptomics 
During transcription, the genetic sequence is transcribed from DNA into messenger 
ribonucleic acid (mRNA) molecules. The precursor mRNA contains regions of exons and 
introns. Introns are removed by RNA splicing and a gene can give rise to several types of 
mRNA splice variants, depending on the combination of exons in the final transcript. 
Transcriptomics refers to the study of these transcripts. Much like DNA methylation, 
transcripts are tissue- and time-specific. The level of expression can be assessed through 
mRNA sequencing, although microarray-based methods are convenient and relatively cheap 
in comparison. A tool for identifying genetic variants influencing expression is to perform 
expression quantitative trait locus (eQTL) analyses investigating the association between a 
SNP and the expression level of a transcript. Expression levels can also be investigated in 
association with disease outcomes or exposures of interest. 
 
2.5 CONCEPTS OF GENE-ENVIRONMENT INTERACTIONS 
In an epidemiological context, an interaction occurs when two or more factors are dependent 
on each other, for example when the strength and direction of association between an 
environmental exposure and an allergic disease differ between the strata of the genetic 
background in an individual126. As discussed above, asthma and allergy are complex diseases 
A 
C U U 
PCR 
PCRs 
A 
T 
Bisulfite 
conversion 
G 
C C C 
PCR 
PCRs 
A 
C 
Bisulfite 
conversion 
Figure 2.2 After bisulfite treatment, unmethylated 
cytosine (C) is converted to uracil (U), whereas 
methylated C is unaffected. During the first round 
of polymerase chain reaction (PCR) U will pair up 
with adenine (A) and in later steps A will pair up 
with thymine (T). 
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with causal mechanisms involving several single causal components such as genes, the 
environment and probably timing of exposure.  
Studying one genetic and one environmental factor in relation to disease has been commonly 
used in asthma epidemiology, using a candidate gene approach. In GWISs, statistical power 
is typically challenging, which calls for international collaborations and alternative statistical 
approaches. In addition, interactions between several genes and environmental factors may be 
a necessary causal mechanism for the disease to occur and higher-order interaction between 
multiple factors is difficult to assess. It is also possible that several different causal 
mechanisms can lead to the same phenotype. Even if we will not be able to identify all 
necessary factors for disease initiation by studying simple GxE interactions (i.e. one variant – 
one exposure interaction), identification of one or more of these factors could possibly lead to 
new insights into the disease mechanisms127. 
In statistics, interaction refers to the departure from the underlying form of a statistical 
model128. When adding an interaction term to a logistic regression model, the interaction is 
measured on the multiplicative scale. Presence of interaction means departure from 
multiplicativity and is a measure of relative risk. An interaction term in a linear regression 
model means departure from additivity and measures absolute risks. 
The statistical power of a study is the probability of rejecting the null hypothesis given that 
the alternative hypothesis is true, i.e., the capability of observing an effect if the effect 
actually exists. With higher power, the risk of false negatives (Type II errors) decreases. 
Power calculations can be used to assess the number of subjects needed in an analysis in 
order to detect an effect of a certain strength. Power is considered a common problem when 
performing interaction analyses; even more so when performing genome-wide interaction 
studies, where adjustment for the high number of tests is necessary. To gain statistical power 
in the performance of a GWIS, a large sample size and efficient analytical approaches are 
crucial112, 113. 
Given the complexity of studying interactions between genetic and environmental factors in 
relation to childhood respiratory and allergic disease and the fact that the underlying 
mechanism is not completely known, the availability of new techniques, analysis approaches 
and the construction of large consortia offers new possibilities to study GxE in relation to 
asthma and allergic disease. 
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3 AIMS 
The overall aim of this thesis was to study the role of genetic polymorphisms and epigenetic 
alterations in interaction with environmental factors related to childhood respiratory and 
allergic disease. 
Study-specific aims: 
I. To investigate if the association between early exposure to mold at home in 
relation to respiratory and allergic disease in children is modified by the 
functional GSTP1 single nucleotide polymorphism Ile105Val. 
 
II. To study DNA methylation in the NPSR1 gene in relation to asthma and 
environmental exposures. 
 
III. To identify interactions between genome-wide single nucleotide polymorphisms 
and air pollution exposure in relation to childhood asthma, with further functional 
analyses of identified loci at the epigenetic and transcriptomic levels. 
 
IV. To study the association between dietary antioxidant intake and development of 
asthma and allergic disease, and to assess potential effect modification by known 
risk factors. 
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4 MATERIAL AND METHODS 
4.1 THE BAMSE BIRTH COHORT 
All four studies in this thesis include data from the BAMSE study 
(Swedish abbreviation for Children, Allergy, Milieu, Stockholm, 
Epidemiological study). BAMSE is a prospective population-based 
birth cohort from Stockholm, Sweden129. The aim of BAMSE was to 
study the impact of environmental and life-style factors on asthma and 
allergy in childhood. Enrollment took place between February 1994 and November 1996. At 
their first child health visit, parents of all newborn children in four predefined areas of 
Stockholm County were asked to participate (Figure 4.1). The areas represented inner city, 
urban and suburban areas comprising different types of buildings, traffic air pollution levels 
and socioeconomic status of parents. 
Figure 4.1. The four predefined recruitment areas of Stockholm County, Sweden for the BAMSE birth cohort. 
Maps adapted from ©OpenStreetMap contributors. 
Questionnaires concerning baseline characteristics, such as perinatal conditions, socio-
economy and parental allergic diseases, were mailed to the parents when the children were 
two months old. Out of the 7,221 newborns, 477 had unavailable addresses and 1,256 were 
actively excluded because the family planned to move within one year of the study start, the 
parents had inadequate knowledge of the Swedish language, the family had a seriously ill 
child, or an older sibling already participated in the study. Of the 5,488 eligible children, 502 
parents declined participation and 897 never answered the inclusion questionnaire which 
resulted in a final cohort of 4,089 children. Through the years, questionnaires regarding 
symptoms of allergic disease, lifestyle factors and major exposures have been filled out by 
their parents, and the children have participated in clinical examinations including blood 
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sampling and lung function measurements (Figure 4.2). When the children were 4, 8 and 16 
years of age, blood samples were analyzed with ImmunoCAP for specific IgE antibodies to 
common inhalant allergens (cat, dog, horse, birch, timothy, mugwort, Dermatophagoides 
pteronyssinus and Cladosporium) using the Phadiatop mix, and to food allergens (cow’s 
milk, hen’s egg, codfish, soybean, peanut and wheat) using the fx5 mix8. 
 
 
Figure 4.2 Flow chart of the BAMSE birth cohort with initial inclusion and follow-up periods with number of 
parents (or adolescents) who answered the questionnaire and number of blood samples obtained at the 
clinical examinations. FFQ: food frequency questionnaire. 
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DNA was extracted from peripheral blood samples when the children were aged 4, 8 and 16 
years. Gene-specific and genome-wide genotyping as well as genome-wide DNA methylation 
and transcriptome analyses have been performed (see section 4.5.3 to 4.5.6). At the clinical 
examination at 8 years of age the parents alone or together with the child answered a FFQ 
about the child’s consumption of 98 common food and drink items during the previous 12 
months (see section 4.5.7). 
Individual estimates of annual air pollution levels have been calculated using both dispersion 
models and LUR models at home, day care and school addresses from birth up to the 16 year 
follow-up (see section 4.5.2). 
 
4.2 OTHER COHORTS 
In studies I and III meta-analyses were performed including children from European and 
North American cohorts as part of the TAG (Traffic pollution, Asthma and Genetics) 
collaboration. The aim of the TAG collaboration was to assess interactions between traffic air 
pollution and genetics and the risk of childhood asthma development. The collaboration 
included, apart from BAMSE, other similar birth cohorts with the aim to study risk factors for 
asthma and allergic diseases, with available information on individual-level traffic air 
pollution exposure, allergic disease status and genetics (n = 11,760 children)130. The included 
cohorts were GINI (German Infant study on the influence of Nutritional Intervention plus 
environmental and genetic influences on allergy development)131, LISA (Lifestyle related 
factors, Immune System and the development of Allergies in East and West Germany plus 
the influence of traffic emissions and genetics study)132, PIAMA (Prevention and Incidence 
of Asthma and Mite Allergy)133, CAPPS (Canadian Asthma Primary Prevention Study)134, 
SAGE (Study of Asthma, Genes, and Environment)135 and ALSPAC (Avon Longitudinal 
Study of Parents and Children)136 (Table 4.1). In addition, the American childhood asthma 
study CHS (Children’s Health Study) was included as a look-up dataset in study III (see 
below). 
Study II comprises data from the BIOAIR (Longitudinal assessment of clinical course and 
BIOmarkers in severe chronic AIRway disease) cohort. The BIOAIR cohort includes 233 
adult patients with severe asthma, mild-to-moderate asthma or COPD, from 12 centers in 9 
European countries137. The aim was to study severe asthma and the patients were followed up 
for one year, starting in 2001. Baseline data from BIOAIR, obtained through questionnaires, 
measurements of lung function and peripheral blood sampling for genotyping and DNA 
methylation, have been used in study II. 
CHS, a longitudinal study of several cohorts from Southern California, USA has investigated 
long-term effects of air pollution on respiratory health in children138. In 1993, 1996 and 2003, 
children aged 5-14 years were recruited from 16 Southern California communities, with 
follow-up in 2007. Data on GWAS, air pollution and asthma status were used for look-up of 
main findings in study III. 
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Table 4.1 Overview of the birth cohorts included in this thesis. Acronyms and study areas, study design, 
recruitment period, the number of subjects enrolled in each cohort at baseline and in studies I-IV 
Study Study design Recruitment N 
baseline 
N  
study I 
N  
study II 
N  
study III 
N  
study IV 
ALSPAC,  
Bristol, UK 
Population based birth 
cohort 
1991-1992 14,541 8,639 - - - 
BAMSE, Stockholm, 
Sweden 
Population based birth 
cohort 
1994-1996 4,089 956 546 481 2,359 
CAPPS, Vancouver and 
Winnipeg, Canada 
Birth cohort with asthma 
intervention for high-risk 
infants 
1995 549 351 - 186 including 
SAGE 
- 
GINI, Munich and 
Wesel, Germany 
Population based birth 
cohort with nutrition 
intervention 
1995-1998 5,991 1,778 - 725 including 
LISA 
- 
LISA, Munich, Wesel, 
Bad Honnef and 
Leipzig, Germany 
Population based birth 
cohort 
1997-1999 3,097 996 
 
see GINI 
 
PIAMA, The 
Netherlands 
Population based birth 
cohort with mattress 
cover intervention and  
allergic/non-allergic 
parents 
1996-1997 4,146 1,875 - 328 - 
SAGE, Manitoba, 
Canada 
Population based birth 
cohort 
1995 16,320 - - see CAPPS - 
 
4.3 FUNCTIONAL STUDIES AND BIOINFORMATICS RESOURCES 
Studies II and III include functional studies with biosamples from adults and data from 
online resources (in addition to data from BAMSE and other cohorts) as described below. 
The MALF study in Stockholm provided blood samples from six adult male healthy 
controls. Previously isolated peripheral blood mononuclear cells (CD4+ T cells, CD8+ T-
cells, CD56+ NK cells, CD19+ B cells, CD14+ monocytes) and granulocytes (neutrophils 
and eosinophils) were investigated for DNA methylation status in the NPSR1 promoter using 
the Illumina 450K array (see section 4.5.5) (study II)117. 
Nuclear extracts from colon adenocarcinoma cells and human embryonic kidney cells were 
investigated for nuclear protein binding in relation to genotype and DNA methylation status 
in NPSR1 in study II, using electrophoretic mobility shift assay (EMSA), in four out of 
twelve CpG sites in the predicted NPSR1 promoter. 
A data resource of lung tissue from 1,111 human subjects who underwent lung surgery at 
Laval University, University of British Columbia or University of Groningen was used for 
functional follow-up of GWAS findings in study III. The subjects were previously analyzed 
for whole genome genotyping and genome-wide transcriptomics139, 140. 
Blood samples from sixteen adult non-smokers with asthma and/or airway hyper-
responsiveness were previously analyzed for genome-wide DNA methylation pre- and post-
diesel exhaust exposure141. These data were used for functional follow-up of GWAS 
findings in study III. 
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The GTEx (Genotype-Tissue Expression) project is a resource database that enables tissue-
specific study of genetic variation in relation to gene expression142. Data from 338 blood 
donors were used for functional follow-up of GWAS findings in study III. 
FANTOM5 (Functional ANnoTation Of the Mammalian genome) is a database of human 
cell-type-specific gene expression that was used in study III to check gene expression of 
GWAS findings in different tissues143, 144. 
The Human Protein Atlas is a database providing information of protein expression for all 
major human tissues and organs145. It was used in study III to identify protein expression in 
normal respiratory epithelial cells, pneumocytes, lung macrophages and smooth muscle tissue 
of the lung. 
 
4.4 STUDY POPULATIONS AND STUDY DESIGN 
Study I included children from the birth cohorts BAMSE, GINI, LISA, PIAMA, CAPPS and 
ALSPAC with information available on early mold and/or dampness exposure, GSTP1 
(rs1695) genotype as well as respiratory and allergic outcomes up to 8 years of age. In total, 
14,495 children had information on genotype. 
Study II included asthma cases and controls from the 8-year follow-up in BAMSE (n = 546) 
and adult patients with mild-to-moderate asthma, severe asthma and COPD from BIOAIR (n 
= 171) with information available on genotype and DNA methylation status in the NPSR1 
promoter. Functional analyses were made in nuclear extracts from colon adenocarcinoma 
cells and human embryonic kidney cells (EMSA) and in cell-sorted peripheral blood from six 
healthy male donors (CpG site methylation). 
Study III included asthma cases and controls from the cohorts BAMSE, GINI, LISA, 
PIAMA, CAPPS, SAGE and CHS, who were approximately 8 years of age, with GWAS data 
and individual traffic air pollution exposure (NO2) data available (n = 3,322). Functional 
follow-up with DNA methylation and gene expression analysis was performed. Blood 
samples from 460 8-year-olds in BAMSE and from sixteen adults with asthma and/or airway 
hyper-responsiveness were investigated for DNA methylation. Blood samples from 263 16- 
year-olds in BAMSE and lung specimens from 1,111 adults were investigated for gene 
expression. The online resources GTEx, FANTOM5 and Human Protein Atlas were used 
(Table 4.2).  
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Table 4.2 Summary of study material and study design for study III 
 Material Association tested Statistical 
analysis 
Covariates adjusted for 
GWIS  
meta-analysis 
BAMSE, GINI/LISA, 
PIAMA 
N = 1,534 
SNPxNO2 at birth  
asthma1 
Logistic 
regression, 
Two-step 
approach, 
2 df test 
Age, sex, city or region at 
birth, smoking, ancestry 
SNPs with interaction p < 1x10-4 selected for look-up (n = 186 SNPs) 
Look-up CHS2 
N = 1,602 
SNPxNO2 at 8 y  
asthma 
Logistic 
regression 
Age, sex, community, 
smoking, ancestry 
 CAPPS and SAGE  
N = 186 
SNPxNO2 at birth  
asthma 
Logistic 
regression 
Age, sex, city or region at 
birth, smoking, ancestry 
SNPs with interaction p < 0.05 selected for functional follow-up (n = 8 SNPs) 
 
Transcriptomics  
+/-250kb of SNP 
Lung tissue 
N = 1,111 
eQTL Linear 
regression 
Age, sex, smoking status 
Transcriptomics  
+/-250kb of SNP 
BAMSE 16 y 
N = 250 
NO2 at birth  
expression at 16 y 
Linear 
regression 
Age, sex, peripheral 
blood cell count3 
Transcriptomics GTEx blood donors  
N = 338  
eQTL   
Look-up of GTEx 
SNPs 
BAMSE 16 y 
N = 173 
eQTL Linear 
regression 
 
Gene expression FAMTOM5    
Protein expression Human Protein Atlas    
     
Epigenetics 
+/-50kb of genes 
Adults with asthma 
and/or airway hyper-
responsiveness  
N = 16 
Diesel  
methylation 
Linear 
mixed 
effects 
modelling 
Peripheral blood cell 
count 
Epigenetics 
+/-50kb of genes 
BAMSE 8 y  
N = 460 
NO2 at birth  
methylation 
Robust 
linear 
regression 
Age, sex, smoking, region 
at birth, asthma1, blood 
cell count4, batch5 
Smoking: parental-reported environmental tobacco smoke exposure, during the first year of life for all cohorts 
except CHS and SAGE, which reported at baseline (mean 8.8 years of age) and 8 years of age, respectively. Kb: 
kilobases. 1Asthma: doctor’s diagnosis of asthma ever, up to 8 years of age. 2CHS reported all variables at baseline 
(mean 8.8 years of age). 3Erythrocytes, platelets, lymphocytes, monocytes, neutrophils, eosinophils and basophils. 
4Estimated counts of CD4+ T cells, CD8+ T cells, NK cells, B cells, monocytes and neutrophils. 5Bisulfite treatment 
date.  
Study IV included all children from BAMSE who had answered the questionnaires at 8 and 
16 years, as well as the FFQ at 8 years. Children were excluded if their mean energy intake 
was below or above 3 log standard deviations (corresponding to ≤ 842.5 or ≥ 3961.1 kcal per 
day). The study compromised 2,359 children. 
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4.5 ASSESSMENT OF EXPOSURES AND COVARIATES 
4.5.1 Indoor mold and smoking 
Information on exposure and covariates that were based on questionnaires answered by the 
parents at each follow-up, or by adults in the BIOAIR cohort, are listen in Table 4.3 below. 
Table 4.3 Exposure and covariates obtained from questionnaires 
Exposures Definition Study 
Mold Mold and/or dampness in any room of the home during 
the first 2 years of life (yes/no) 
I 
Parental smoking in infancy (birth) Daily parental tobacco smoke exposure at birth of the 
child (yes/no) 
II, III 
Current parental smoking (8y) Daily parental tobacco smoke exposure at child’s age 8 
years (yes/no) 
II, IV 
Smoking status (adults) Never-smoker, former smoker, current smoker at 
baseline 
II 
 
4.5.2 Traffic-related air pollution  
In studies II and IV, annual averages of traffic-NOx exposure were estimated using 
dispersion modelling146, 147. In study III, annual averages of traffic-NO2 exposure were 
estimated using LUR models148. For BAMSE, addresses were obtained from the 
questionnaires and converted into geographical coordinates using a property register managed 
by the Swedish mapping, cadastral and land registration authority. Missing address 
information was obtained from the tax authority. Estimated averages were calculated for 
addresses in Stockholm and Uppsala counties. 
4.5.2.1 Dispersion modelling 
Information about various sources contributing to measured air pollutants was acquired from 
an emission database administered by the Stockholm and Uppsala Air Quality Management 
Association149. Road traffic-NOx was used as a marker for exhaust particles and emission 
databases for traffic-NOx used in this thesis were available from 1990, 1995, 2000, 2002, 
2003, and 2004150. Time- and space-resolved emissions from traffic (including road type, 
traffic counts, the proportion of heavy traffic and speed limits) at road links were calculated 
by SLB analysis at the Stockholm Environment and Health Administration using the EVA 
model151. Linear interpolations were made to obtain traffic-NOx concentrations for all years.  
Annual mean concentrations of traffic-NOx in the study areas were calculated using a 
Gaussian air quality dispersion model and a wind model, both part of the Airviro Air Quality 
Management System152, including meteorological conditions and topography. Concentrations 
were calculated using a 25 m resolution grid in urban areas. Less populated urban areas and 
suburban areas used 100 m and 500 m resolution grids, respectively. To compensate for the 
coarse resolution of the dispersion calculations over suburban areas, additional adjustments 
were made based on the concentration gradient from roads with more than 10,000 vehicles 
 24 
per day. The impact of street canyons of the most polluted street segments with multistory 
houses on both sides in the Stockholm inner city area was accounted for using an Airviro 
street canyon model152 for addresses located closer than 30 m to such street segments.  
Time-weighted average exposure to NOx was estimated for each child depending on the 
duration of time spent at the different addresses. If two home addresses were reported for the 
same time period, the child was assumed to spend 50% of its time at each place. For the first 
year of life, only residential addresses were considered since children in Sweden seldom start 
day care before 1 year of age. Dispersion data was included in studies II and IV. 
4.5.2.2 Land Use Regression modelling 
In study III, annual average of traffic-NO2 exposure estimates at birth addresses for all 
European cohorts were obtained from LUR models developed through the ESCAPE 
(European Study of Cohorts for Air Pollution Effects) project148. In BAMSE, a LUR 
modelling was also performed for home addresses at the time of the 16-year follow-up.  
Measurements of NO2 were performed between October 2008 and April 2011 at 40 sites 
within each study area including regional background, urban background and traffic sites. 
NO2 was measured for 2 weeks in warm, cold and intermediate seasons and an average 
annual estimate was calculated. Each study area had a background reference site with 
continuous measurement of NO2 that was used to adjust for temporal variation.  
LUR models were developed based on the calculated annual concentration and potential 
predictors from European-wide as well as local Geographical Information System (GIS) 
databases. Predictors including digital road network, land use, population density, altitude 
and study-specific local data were added to the model using a supervised forward stepwise 
procedure, in order to explain the spatial variation of NO2. One model was developed per 
study center.  
LUR model exposure data for CAPPS and SAGE children born in Winnipeg were based on 
measurement campaigns from 2007153. For CHS, regional air pollution was measured 
continuously from central site monitors in 16 communities. Annual averages for when the 
children were 8.8 years were calculated and used for analysis154, 155. 
4.5.2.3 Short-term diesel exhaust exposure 
In a double-blind cross-over study, 16 adult asthmatics free from current use of asthma 
medications were exposed to filtered air or diesel exhaust at a concentration of 300 µg/m3 
(containing 0.22 ppm NO2) for 2 hours at two time points, two weeks apart
141. Throughout 
the exposure, the participants alternated between light exercise on a stationary bicycle for 15 
minutes and rest for 45 minutes. 
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4.5.3 SNP genotyping 
SNPs in Table 4.4 below were analyzed in studies I, II and IV. In BAMSE, GSTP1, TNF 
and NPSR1 SNP genotyping was performed through matrix-assisted laser 
desorption/ionization-time of flight (MALDI-TOF) mass spectrometry (Sequenom, San 
Diego, CA, USA) as earlier described81, 156. Genotyping of GSTP1 in GINI and LISA was 
performed using the restriction fragment length polymorphism approach157. PIAMA and 
ALSPAC used the Competitive Allele-Specific PCR (KASPar) genotyping chemistry 
(KBiosciences, Hoddesdon, Herts, UK)158, 159 and CAPPS used the Illumina BeadArray 
system (Illumina, San Diego, CA, USA) for GSTP1 genotyping96. In BIOAIR, NPSR1 SNP 
genotyping was performed using TaqMan allelic discrimination on the ABI Prism 7500 
detection system156.  
Table 4.4 Summary of genes, SNPs and the number of cases and controls from the BAMSE birth 
cohort that were genotyped for each SNP in studies I, II and IV 
Gene SNP ID N cases and controls Study 
GSTP1 rs1695 (Ile105Val) 497 with any wheezing up to 4 
years of age and 485 never-
wheezers  
I, IV 
 rs762803, rs749174, rs1138272 
(Ala114Val), rs1871042, rs4891 
IV 
TNF rs1799964, rs1799724, rs1800629 (-
308G/A), rs1800610, rs3093664 
IV 
NPSR1 rs2168891, rs2168890, rs2530547, 
rs887020 
273 with doctor’s diagnosis of 
asthma ever, up to 8 years of 
age and 273 never asthmatics 
II 
 
4.5.4 GWAS 
In study III, genome-wide SNP genotyping was performed with a chip-based method. The 
following platforms were used: Illumina 610-Quad BeadChip (BAMSE, PIAMA, CAPPS 
and SAGE)106, Affymetrix 5.0 (GINI and LISA)160, Illumina HumanHap550, HumanHap550-
Duo or Human610-Quad BeadChip (CHS)161, Illumina Human1M-Duo BeadChip (Lung 
tissue data) 139. Imputation based on HapMap 22, NCBI build 36, resulted in more than 2 
million overlapping SNPs between the discovery cohorts. Details on quality control (QC) of 
samples are provided in the original manuscripts. 
4.5.5 Epigenetics 
For study II, peripheral blood cell DNA was bisulfite-treated using EZ-96 DNA Methylation 
Kit (Zymo Research Corporation, Irvine, CA, USA) and analyzed for DNA methylation in 
the predicted NPSR1 promoter using EpiTYPER162. Five CpG sites from 8-year-olds in 
BAMSE and 12 CpG sites from adults in BIOAIR were assessed. For the six healthy male 
donors, DNA was bisulfite-treated and analyzed on the Illumina Infinium 
HumanMethylation450 BeadChip (Illumina 450K) (Illumina Inc., San Diego, CA, USA) as 
well as using EpiTYPER117.  
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Blood samples from 460 8-year-olds with asthma and controls in BAMSE and from sixteen 
adult non-smokers with asthma and/or airway hyper-responsiveness were assessed for whole 
genome methylation using bisulfite treatment and Illumina 450K123. In the sixteen adults, 
blood was collected pre- and 6 h as well as 30 h post-exposure to filtered air and diesel 
exhaust141. Details on QC of samples are provided in the respective original manuscripts and 
the original manuscript for study III. 
4.5.6 Transcriptomics 
In study III, blood samples from 263 16-year-old participants in BAMSE were investigated 
for gene expression using the Affymetrix Human Transcriptome Array 2.0 Genechips 
(Affymetrix, Inc., Santa Clara, CA, USA) (173 of these had GWAS data available and 250 
had NO2 data available)
123. The lung tissue data from adults was obtained through whole-
genome expression profiling using an Affymetrix custom array (see GEO platform 
GPL10379, http://www.ncbi.nlm.nih.gov/geo/)139, 140. Details on QC of samples are provided 
in the original manuscripts. 
4.5.7 Food frequency questionnaire 
A FFQ was filled out by the parents alone or together with the child at the 8-year clinical 
examination within BAMSE (n = 2,614). The FFQ contained questions about the average 
consumption during the previous 12 months of 98 foods and beverages frequently consumed 
in Sweden. There were ten pre-specified response categories ranging from 0 times/month to ≥ 
3 times/day. The FFQ has been transformed into individual energy and nutrient intake using 
composition values obtained from the Swedish National Food Administration Database163. 
Variability in nutrient intake caused by differences in total energy consumption was managed 
by energy-adjusting the calculated nutrient levels using the residual method164. 
The concept of TAC was used to assess children’s total dietary antioxidant intake (study IV). 
Estimated dietary TAC values (μmol Trolox equivalents/g (TE/g)) for food and drink items 
included in our FFQ were derived from a United States (US) database165. One hundred foods 
and drinks commonly consumed in the US had been assessed for their TAC content using the 
oxygen radical absorbance capacity (ORAC) assay166. Of these 100 items, 35 were available 
in our FFQ (Table 4.5). The amount of intake of each food item in the FFQ was multiplied 
with its respective estimated TAC value. Total dietary TAC (μmol TE/day) was obtained by 
summarizing TAC values for all food items eaten and energy-adjusting using the residual 
method164. 
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Table 4.5 Food items from the FFQ at 8 years with available ORAC-TAC estimates that 
contributed with > 1% to the total ORAC-TAC in study IV (19 of 35 food items) 
Food item Average proportion of 
ORAC-TAC (%)1 
Apple, pear 23.3% 
Juice 10.3% 
Chocolate milk 9.1% 
Boiled potato 7.5% 
Other fruit (apricot, kiwi, nectarine, peach, plum, grapes) 6.1% 
Orange, citrus fruit 4.5% 
Stewed fruit, fruit soup 4.0% 
Rye bread 3.3% 
Berries (blackberry, blueberry, raspberry, strawberry) 3.2% 
Banana 2.8% 
Mashed potato 2.7% 
Whole meal bread 2.6% 
Tea 2.5% 
Carrot (raw, canned, cooked) 2.2% 
Breakfast cereal 2.2% 
Oatmeal 2.1% 
Chocolate 2.0% 
Jam, marmalade 1.5% 
Crisp bread 1.4% 
1Calculated by combining the estimated ORAC-TAC value and the frequency of consumption. 
 
4.5.8 Other characteristics 
Sampling season: the time of year when blood samples were collected at the 8-year clinical 
examination was used in study II and divided into three-month intervals for analysis: 
January-March (reference group), April-June, July-September, and October-December. 
Body mass index: body mass index at 8 years of age in BAMSE and at baseline in BIOAIR 
was measured in kg/m2 based on height and weight information (study II). 
 
4.6 DEFINITION OF HEALTH OUTCOMES 
4.6.1 Asthma and allergy-related health outcomes 
The asthma and allergy-related health outcomes were assessed through questionnaires filled 
out by parents at each follow-up (Table 4.6). 
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Table 4.6 Definitions of health outcomes 
Variable Definition Study 
Children   
Early wheezing (0-2 y) Any parental-reported wheezing or whistling in the chest up to 
two years of age. 
 I 
Early asthma (0-3y) 
School-age asthma (6-8 y) 
Asthma (16 y) 
Parental-report of at least two of the following three conditions: 
ever doctor’s diagnosis of asthma, wheezing in the last 12 months 
and asthma medication in the last 12 months. Teenagers’ own 
reports were used at 16 y. 
I (0-3 & 
6-8 y) 
IV (8 & 
16 y)1 
Current asthma (8 y) Parental-reported ever doctor’s diagnosis of asthma up to 8 years 
in combination with at least one episode of wheeze in the last 12 
months. 
II 
Allergic asthma (8 y) Parental-reported ever doctor’s diagnosis of asthma up to 8 years 
in combination with an IgE-value for inhalant allergens ≥ 0.35 kU/l 
at 8 y. Controls were children with no history of asthma or other 
allergic diseases. 
II 
Non-allergic asthma (8 y) Parental-reported ever doctor’s diagnosis of asthma up to 8 years 
in combination with an IgE-value for inhalant allergens < 0.35 kU/l 
at 8 y. Controls were children with no history of asthma or other 
allergic diseases. 
II 
Ever doctor’s diagnosis of 
asthma (0-8 y) 
Parental-reported ever doctors doctor’s diagnosis of asthma (up to 
approximately 8 years of age). 
CAPPS: clinical examinations by a pediatric allergist at 7 y. 
SAGE: parental-reported doctor’s diagnosis of asthma at 7 y with 
confirmation of the diagnose by a pediatric allergist (mean age 9y). 
CHS: parental-reported (or self-reported) doctor’s diagnosis of 
asthma at baseline (1994-2003, age range 5-14 years) or at any 
time during the follow-up (until 2007). 
II 
III 
Allergic asthma (16 y) A combination of asthma (16 y) and sensitization (16 y) against any 
inhalant allergen.  
IV1 
School-age nasal 
symptoms (6-8 y) 
Parental-reported prolonged sneezing, runny or blocked nose 
without common cold or flu in the last 12 months. 
CAPPS: Physician-diagnosed rhinitis. 
 I 
Ever nasal symptoms 
(2-10 y) 
Same as School age nasal symptoms 6-8 y.  I 
School-age rhino-
conjunctivitis (6-8 y) 
Parental-reported runny, itchy eyes in addition to nasal symptoms.  I 
Rhinitis (8 or 16 y) Parental-reported prolonged sneezing, runny or blocked nose 
without common cold or flu in the last 12 months, and/or nose or 
eye symptoms after contact with furred pets and/or pollen after 4 
years of age for rhinitis at 8 years of age, or after contact with 
furred pets and/or pollen in the last 12 months for rhinitis at 16 
years of age. Teenagers’ own reports were used at 16 y. 
IV1 
Allergic rhinitis (16 y) A combination of rhinitis (16 y) and sensitization against any 
inhalant allergen (16 y). 
IV1 
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Adults   
Mild-to-moderate 
asthmatics 
Patients had stable disease and received daily treatment with a 
maximum of 800 μg/day budesonide or beclomethasone, 500 μg/day 
fluticasone or equivalent. The patients used short‐acting β‐agonists as 
needed but did not require treatment with long‐acting β‐agonists and 
had had neither exacerbations nor hospitalizations in the past year.  
II 
Severe asthma Specialist treatment for at least 1 year and at least one exacerbation 
requiring oral steroid treatment in the past year, despite continuous 
treatment with high doses of inhaled corticosteroids (ICS; at least 
1,600 µg/day budesonide or beclomethasone, 800 µg/day fluticasone 
or equivalent), and long-acting β-agonists or oral theophylline for at 
least 1 year. 
II 
COPD Physician-diagnosed chronic obstructive pulmonary disease.  II 
FEV1 Forced Expiratory Volume in 1 second (the air exhaled in one second 
in spirometry test at baseline). 
 II 
FVC Forced Vital Capacity (the total volume of air exhaled in spirometry 
test at baseline). 
 II 
1Onset of allergic disease between 8 and 16 years of age was defined as fulfilling the definition at 16 
years but not at 8 years of age. 
 
4.6.2 Sensitization 
Sensitization to inhalant allergens in BAMSE was defined as a specific IgE result of ≥ 0.35 
kUA/L against cat, dog, horse, birch, timothy, mugwort, Dermatophagoides pteronyssinus or 
Cladosporium (at 8 years in study I, II and IV and also at 16 years in study IV). In study I, 
sensitization to inhalant allergens at 6-8 years of age in BAMSE, GINI, LISA and PIAMA 
was defined as a specific IgE result of ≥ 0.35 kUA/L against at least one of the measured 
inhalant allergens in each separate cohort. Sensitization in ALSPAC and CAPPS was 
assessed by skin prick test (SPT) with a positive reaction of having a wheal diameter of > 2 
mm to at least one of the measured inhalant allergens. Allergic disease was defined as a 
combination of the health outcome and sensitization according to the definitions above. 
 
4.7 STATISTICAL ANALYSES 
For study I, main effects of early exposure to mold at home as well as GSTP1 polymorphism 
rs1695 in relation to respiratory and allergic disease in children were assessed using logistic 
regression analysis, adjusting for sex, parental allergy and maternal smoking during 
pregnancy (although CAPPS did not adjust for smoking due to lack of information). 
Interaction between early exposure to mold and the GSTP1 polymorphism was tested by 
inclusion of an interaction term in the model and stratification by genotype. Meta-analysis 
with random effect model was used to account for heterogeneity between cohorts. 
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In study II, asthma status and environmental exposures in relation to DNA methylation in 
NPSR1 was assessed using linear regression analysis, adjusting for age and sex as well as 
country of origin in adults and batch effect in children. Results were presented as beta-values 
per unit change in the exposure level, with corresponding p value. Traffic-NOx estimates in 
BAMSE were assessed by the 5th to 95th percentile difference in NOx exposure levels, 
corresponding to 45.7 µg/m3 during the first year of life, and 26.0 µg/m3 for current exposure 
at eight years of age. Analyses of air pollution were additionally adjusted for municipality at 
birth. If a CpG site coincided with a SNP causing or destroying a CpG site the analysis was 
restricted to homozygous carriers of the allele creating a CpG site. 
Statistical analyses for study III are summarized in Table 4.2. Interactions between genome-
wide SNPs and NO2 exposure (per 10 µg/m
3 increase) in relation to childhood asthma were 
assessed using logistic regression. Fixed effect model with sample size weighted analysis 
was used in the GWIS meta-analysis. Robust linear regression was used to account for 
influential outliers and potential heteroscedasticity in the methylation data in relation to NO2 
exposure data. Since methylation data were obtained from whole blood, adjustment for cell 
type composition was performed using the Houseman reference-based method167. Linear 
regression was applied for the lung eQTL analyses. Meta-analysis using a fixed effect model 
was performed with inverse variance weighting. The linear mixed effects model is a 
statistical model used for repeated measures that contain fixed effects and random effects. It 
was applied to the measurements comparing post-diesel exhaust particles (DEP) vs. pre-DEP, 
and post-filtered air particles (FAP) vs. pre-FAP in order to identify CpG sites that were 
differentially methylated as a result of diesel exhaust exposure but not filtered air. Log-linear 
regression on NO2 exposure in relation to gene expression values was performed in BAMSE 
and adjusted for cell counts. Log-linear regression was also used to analyze eQTLs in 
BAMSE. Correction for multiple testing was done to limit false positive occurrences. For 
Bonferroni correction the significance level of 0.05 was divided by the number of hypotheses 
tested in order to obtain an adjusted significance threshold. The false discovery rate (FDR) 
significance threshold of 5% was calculated by ranking the p values from lowest to highest 
and multiplying the rank by 0.05, and the product was divided by the number of tests168. 
In study IV, logistic regression analysis was performed to investigate the association 
between dietary antioxidant intake (analyzing TAC in tertiles) and development of asthma 
and allergic disease, and to assess potential effect modification by known risk factors. 
Traffic-NOx at 8 years was analyzed in tertiles, corresponding to median (min-max) values of 
3.09 (0.40-4.81), 8.24 (4.82-12.16) and 18.49 (12.21-56.04) µg/m3 for tertiles 1 to 3, 
respectively. Sex, parental history of allergic disease, early maternal smoking and parental 
socioeconomic status (blue-collar or white-collar worker) were adjusted for. Test for trend 
was performed by assigning the median value of dietary TAC within each tertile and tested as 
a continuous variable in the model. 
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4.7.1 Tests for interactions 
Logistic regression with inclusion of an interaction term in the model was used in studies I 
and III and a p value for interaction was obtained. LRT between the model with and without 
interaction term was used to test the null hypothesis of no interaction in study IV. Stratified 
analyses were performed in studies I, III and IV to investigate the direction of effect over 
strata. 
The two-degree-of-freedom (2 df) test112 (study III) jointly tested the main effect of SNP 
and the SNPxNO2 interaction effect by logistic regression, in the context of GWAS. Using 
this test, SNPs with main effects and SNPs with heterogeneity in genetic effects over 
different levels of NO2 exposure will be detected. The p values from the separate k (k = 3) 
cohorts were meta-analyzed using Fisher’s method, which provided a summarized χ2 statistic 
with 2k degrees of freedom169.  
The first step in the two-step approach113 (study III) tested the association between SNPs 
and NO2 in cases and controls combined by linear regression. All SNPs with a p value < 0.05 
were in a second step tested for SNPxNO2 interaction using logistic regression. A summary 
of the two-step approach is presented in Table 4.7. Step one is based on the case-only 
method, where associations between genetic variants and environmental exposure are tested 
in cases only, using linear regression. The method relies on the assumption that the genetic 
variants and the environmental exposure are independent in the source population and an 
association between the genetic variant and the environmental exposure will arise among 
cases whenever GxE is present. Analyzing cases only in step one will produce correlations 
between step one and step two test statistics, resulting in an inflated number of false positives 
for the whole test. Therefore, in the current two-step approach, cases and controls were 
analyzed together in step one. The two-step approach is a more powerful method than testing 
for GxE in a case-control setting. 
 
Table 4.7 The two-step approach 
 Statistical model Pros Cons 
Step 1 
 
Linear regression: SNP - NO2 
association in cases and 
controls combined  
Uses a powerful “case-only” 
method that increases the chance of 
identifying true positives. 
Sensitive to the 
independence assumption 
with risk of false positives. 
  Screening step to reduce the 
multiple testing burden in step 2. 
 
Selection of SNPs with p < 0.05 
Step 2  Logistic regression: SNPxNO2 
in relation to asthma using a 
standard case-control setting 
Insensitive to the independence 
assumption. The bias of false 
positives in step one is overcome. 
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4.8 ETHICAL APPROVALS 
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5 RESULTS AND DISCUSSION 
5.1 GENE-ENVIRONMENT INTERACTIONS IN RELATION TO ASTHMA AND 
ALLERGY 
In study I, a meta-analysis of 14,595 children, the association between early exposure to mold 
at home and respiratory and allergic disease was investigated. The main effect analyses of 
early mold exposure showed significant associations with early wheezing and ever nasal 
symptoms during childhood, OR: 1.27 (95% CI: 1.09-1.47) and 1.19 (95% CI: 1.02-1.38), 
respectively, although with indicated heterogeneity between the cohorts (p value for 
heterogeneity < 0.05). We further evaluated potential interaction between early exposure to 
mold and the GSTP1 polymorphism rs1695. We did not find any statistically significant 
interaction with respect to allergic disease outcomes. However, stratification by genotype 
revealed statistically significant associations between mold exposure and school age nasal 
symptoms as well as ever nasal symptoms in the strata of Ile/Ile carriers (OR: 1.20 (95% CI: 
1.00-1.44) and OR: 1.30 (95% CI: 1.04-1.61), respectively), but not in the other genotype 
group (Figure 5.1). 
 
Figure 5.1 Adjusted odds ratios and 95% confidence intervals for the association between early mold exposure 
and wheezing, asthma, nasal symptoms and sensitization to inhalant allergens, stratified by genotype using 
dominant coding. 
 
Systematic reviews and meta-analyses34, 36-40, as well as prospective birth cohort studies170-173, 
have found associations between early life exposure to mold and dampness, and wheezing, 
asthma and rhinitis in children. In line with our results, exposure to visible mold or dampness 
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has not been associated with sensitization, as evaluated in several prospective birth cohort 
studies34, 171-173.  
Mold exposure during first year of life has been significantly associated with increased risk of 
wheezing at 2 years of age, and similar to our study no difference over strata of GSTP1 
genotype was seen82. A cross-sectional Taiwanese study did not find interactions between 
mold exposure and GSTP1 in 12-year-olds with asthma and controls41. Val105 genotype in 
combination with early mold exposure has been associated with current atopic dermatitis in 
3-18-year-olds174. In a previous meta-analysis on 31,742 children173, mold exposure was 
associated with nasal symptoms, and these associations were also seen in Ile/Ile carriers in the 
present study. Our study is the first and only collaborative study that has looked at GxE in 
relation to mold and respiratory and allergic health outcomes using birth cohort data. 
Other genes, such as CHIT1, TNF, IL13 and IL4, which were not tested in the current study, 
have also shown interaction with mold and dampness in relation to wheeze, asthma and 
allergic rhinitis175-178. In summary, in line with other studies, early mold exposure was 
associated with nasal symptoms and early wheezing in children. A positive significant 
association of nasal symptoms in relation to mold exposure was seen primarily in Ile/Ile 
carriers of GSTP1 Ile105Val polymorphisms. However, there seems to be a complex 
interplay between GSTP1 genotype and environmental exposures and interactions could not 
be ruled out. 
In study III, we aimed to identify genetic regions of importance in the association between 
traffic air pollution and childhood asthma. GWISs of SNPs and traffic NO2 in relation to 
childhood asthma up to 8 years of age were performed in three European birth cohorts (n = 
1,534). After meta-analysis, several suggestive loci were identified, although no SNP reached 
a genome-wide significance level, p < 7.2x10-8. Two alternative statistical approaches, the 
two-step approach and the 2 df test, with potentially better power for genome-wide 
interaction analyses, were also used (see below).  
Since the primary GWIS approach was used as a screening tool to identify SNPs and genes 
that may interact with air pollution in asthma, all SNPs with an interaction p value < 1x10-4  
in the primary GWIS approach (n = 186 SNPs) were considered for look-up in CHS (n = 
1,602) and CAPPS/SAGE (n = 186) (Figure 5.2).  
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Figure 5.2 Manhattan plot for the association between SNPxNO2 and asthma from the discovery genome-wide 
interaction meta-analysis. The lower horizontal line indicates the threshold for bringing SNPs forward to look-
up (p < 1x10-4). The upper horizontal dashed line indicates the genome-wide significant threshold using the 2-
step approach (p < 4x10-7). NO2 is per 10µg/m3 increase. 
 
Eight SNPs in the loci of adenylate cyclase 2 (ADCY2), UDPGal:betaGlcNAc beta 1,4- 
galactosyltransferase, polypeptide 5 (B4GALT5), discs large homolog 2 (DLG2) and 
molybdenum cofactor sulfurase (MOCOS) had interaction p values < 0.05 in the larger CHS 
cohort. Three SNPs located within ADCY2 on chromosome 5 (LD r2 = 0.93-1.0) showed 
same direction of interaction effect and same direction in stratified analyses of the association 
between NO2 exposure and childhood asthma, when the discovery meta-analysis was 
compared with CHS (data shown for rs4143882 in Table 5.1). 
Table 5.1 Adjusted odds ratios and 95% confidence intervals for the association between 
NO2 and asthma, stratified by rs4143882 genotype (ADCY2) using dominant coding. 
 Discovery meta-analysis n = 1,534 CHS n = 1,602 
 OR (95% CI) p OR (95% CI) p 
GG 0.81 (0.33-1.99) 4.75x10-5 0.88 (0.76-1.02) 0.015 
AG/AA 1.61 (1.04-2.51)  1.13 (0.98-1.29)  
p: interaction p value using additive coding of SNP. NO2 is per 10 µg/m3 increase. 
 
SNPs in ADCY2 have been associated with pulmonary function in adults179 and a previous 
study in BAMSE’s 8-year-olds reported an association with lung function for these SNPs 
with a suggested interaction with current tobacco smoke exposure180. One SNP in ADCY2181 
and one in DLG2182 has also been associated with COPD. Persistence of childhood asthma 
into adult life is associated with lung function impairment and increased risk of COPD, a 
disease which may have its origin early in life183. 
The two-step approach revealed four genome-wide significant SNPs, rs7651862, 
rs11706125, rs11718057 and rs13066946 close to the membrane-associated guanylate 
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kinase, WW and PDZ domain containing 1 (MAGI1) gene (Figure 5.2). These SNPs had the 
lowest interaction p value in the primary GWIS meta-analysis and they were also nominally 
significant in the 2 df test (p < 0.05). However, the SNP x air pollution interaction was not 
statistically significant in a look-up in the cohorts CHS and CAPPS/SAGE.  
To date, no other interaction study between GWAS and traffic air pollution in association 
with childhood asthma has been published. Many previous GxE attempts using GWAS data 
have failed to reach genome-wide gene-by-environment significance for respiratory diseases 
and lung function. The first GWIS on childhood asthma and tobacco smoke exposure did not 
reveal any genome-wide statistically significant SNPs184. However, suggestive evidence for 
interaction was found for EPB4IL3 (interaction p = 4.29x10-5 in discovery phase and 
replication interaction p = 0.03 for interaction with in utero tobacco smoke exposure) and 
PACRG (interaction p = 1.37x10-5 and interaction p = 0.06 in discovery and replication 
phase respectively for interaction with childhood tobacco smoke exposure). No genome-
wide significant interaction could be identified for common SNP variants (interacting allele 
frequencies from 30 to 70%, for which their study was well powered) and farming lifestyle 
in a GWAS of 1,708 children investigating asthma and atopy185.  Rare variants, particularly 
of SNPs related to the GRM1, belonging to the G protein coupled receptor family, showed 
interaction with farming environment (Bonferroni corrected interaction p < 0.05). GWISs on 
smoking and lung function, studying > 50.000 subjects, have not reached genome-wide 
significance for interaction, although three novel regions of potential importance for lung 
function were identified using the joint 2 df test in the CHARGE and SpiroMeta studies186, 
187. In a study investigating interaction with sex in relation to childhood asthma, functional 
follow-up analyses revealed expression in alveoli and macrophages of the suggested gene 
DMRT1 (interaction p = 5.21x10-6), a gene required for testicular development188. Similarly, 
a GWAS on bronchial hyper-responsiveness in asthmatics identified no genome-wide 
significant hits, although subsequent lung eQTL analyses of the top hit SNPs revealed novel 
genes associated with asthma189. 
There are a few examples of genome-wide significant interaction effects in the field of lung 
function and asthma, one from a Dutch study of 12,400 adults, where interactions between 
seven SNPs and occupational exposures to dust gases and fumes in relation to lung function 
were reported190. Two of the SNPs were identified as lung eQTLs for TMEM176A and 
PDE4D. In addition, a GWIS on lung function decline in adults identified CDH13, a gene 
functionally linked to the adipokine adiponectin, to interact with 11-year cumulative PM10 
exposure (interaction p = 8.8x10-10), using a two-stage GWIS analysis approach191. In a 
recent GWIS in Puerto Rican children with asthma, significant interaction was detected for 
dust mite allergen exposure at home and a SNP close to a transcription factor binding site 
involved in IL-17 signaling pathway in relation to lung function (interaction p = 3.1x10-8)192. 
In conclusion, in study III we found that interaction between SNPs and air pollution exposure 
is important for asthma development. Based on our result and previous GWIS attempts by 
other researchers, we conclude that using a genome-wide significance threshold may be a too 
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conservative cut-off for look-up of GWIS top hit findings, resulting in false negative results 
and missing of important loci involved in asthma development. 
In study IV, the association between dietary antioxidant intake (assessed as dietary TAC) and 
development of asthma and allergic disease was assessed in the BAMSE birth cohort (n = 
2,359). The main effect analyses showed significant inverse association for new onset 
sensitization to inhalant allergens between 8 and 16 years of age (OR: 0.73 (95% CI: 0.55-
0.97) for the 3rd tertile as compared with the 1st, p for trend = 0.031) and for new onset of 
allergic asthma between 8 and 16 years of age (OR: 0.57 (95% CI: 0.34-0.94) for the 3rd 
tertile compared with the 1st, p for trend = 0.029). After additional adjustment for dietary 
intake of specific nutrients, supplement use, and allergic disease in early childhood, the 
results remained significant for sensitization to inhalant allergens. The significant association 
with sensitization to inhalant allergens remained also after consideration of disease-related 
modification of consumption.  
In systematic reviews and meta-analyses, a Mediterranean diet, as well as diets rich in fruits, 
vegetables and vitamins have shown inverse associations with allergic disease outcomes in 
children66, 67, 193. However, a majority of previous studies have been cross-sectional and 
inconsistent results between studies have been seen. 
Inverse associations were detected between fruit intake and current rhinitis in children73, as 
well as between beta-carotene and rhinitis194 in two previous cross-sectional studies. 
However, after adjustment for disease-related modification of consumption, all associations 
became weaker and significance disappeared. These studies indicate the importance of taking 
the concept of disease-related modification of consumption into consideration when studying 
associations between diet and allergic disease outcomes. 
Recent cross-sectional studies in children found inverse associations between dietary intake 
of vitamin C and E and asthma195, and inverse associations between intake of vitamin C and 
allergic rhinitis196. No associations were seen for retinol, beta-carotene, vitamin C or vitamin 
E in relation to sensitization196. An antioxidant-rich diet was inversely associated with 
childhood asthma, but not with rhinitis or sensitization in another cross-sectional study197. A 
longitudinal study found an inverse association between dietary beta-carotene and allergic 
sensitization in children198. However, none of these studies took disease-related modification 
of consumption into consideration. A longitudinal study of serum concentrations of 
carotenoid and tocopherol found no evidence of decreased intake of antioxidants in relation to 
increased asthma prevalence in children199.  
In study IV, significant interaction between dietary TAC and current traffic air pollution 
exposure (NOx) was observed in relation to sensitization to inhalant allergens between 8 and 
16 years of age (interaction p = 0.03), with stronger association among children with low 
levels of traffic air pollution exposure (Figure 5.3). The association was also statistically 
significant in children who had not been exposed to parental smoking, although no interaction 
was detected (interaction p = 0.85). 
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Figure 5.3 Adjusted odds ratios and 95% confidence intervals for the association between dietary TAC intake 
(first tertile vs. second and third tertiles combined) and sensitization to inhalant allergens. Main effect analysis 
for all children and stratified analyses by traffic-NOx exposure in tertiles as well as parental smoking. 
 
One previous cross-sectional study in children found inverse associations for dietary TAC in 
relation to current asthma, and, much like in our study, the effect was only seen in children 
with non-smoking parents200. In adults, dietary TAC had a favorable role in lung function, in 
premenopausal never-smoking women201. A study on lung function in children found 
interaction between ozone and high intake of fruits and vegetables and adherence to a 
Mediterranean diet, suggesting that a high intake could modulate adverse effects by air 
pollutants202.  
Tobacco smoke exposure in children with a low dietary vitamin A intake was associated with 
asthma diagnosis in a cross-sectional study203. Further, homozygous carriers of the GSTP1 
Ile105 allele showed an even larger effect estimate by exposure. Lower lung function in 
children with asthma was reported in carriers of a combined effect of GSTM1, GSTP1 and 
NQO1 polymorphisms, in combination with a low dietary vitamin C intake204. In our study 
IV, we found no significant interactions between dietary TAC and GSTP1- or TNF-
genotypes, although the number of children with both TAC estimates and genotype 
information available was low and interactions cannot be ruled out. Our results should 
therefore be interpreted with caution. In summary, the finding from the stratified analyses in 
study IV indicates that dietary antioxidant intake may protect against allergic sensitization in 
conditions of low oxidative stress. 
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5.2 EPIGENETIC DIFFERENCES IN ASSOCIATION WITH ASTHMA AND 
ENVIRONMENTAL EXPOSURES 
In study II, DNA methylation in the NPSR1 promoter was investigated in relation to asthma 
and environmental exposures in the adult BIOAIR cohort (n = 171), as well as in the BAMSE 
birth cohort (n = 546). Adult severe asthma was inversely associated with DNA methylation 
at CpG site 5 in the promotor region of NPSR1 as compared with in mild asthma (-3.29%, p = 
0.0001). In children, allergic asthmatics compared with never-asthmatics had a 0.6% lower 
level of DNA methylation at both CpG site 1 (p = 0.01) and CpG site 4 (p = 0.03), whereas 
no such associations were found for non-allergic asthmatics. Others have not studied 
differential DNA methylation in NPSR1, but NPSR1 variants have been associated with 
sensitization and allergic asthma in several studies90-92, 98, 205. Gene expression of Npsr1 was 
upregulated in the lung of sensitized mice compared with non-sensitized mice after 
experimentally induced lung inflammation90. NPSR1 polymorphisms have also been 
associated with allergic rhinitis206 and gene-gene interaction between NPSR1 and FGF1 
genotypes was found in one study in relation to sensitization207. EWASs have detected 
differential methylation in several different loci in association with total IgE and childhood 
asthma208-210. In conclusion, significant differences in DNA methylation in the NPSR1 
promoter were detected in associations with asthma-related traits in adults and children, and 
in particular, with allergic asthma in children, which supports previous findings linking 
NPSR1 to asthma and sensitization. 
Smoking in adults showed rather large differences in methylation level compared with never-
smokers. Current smoking was associated with 3.8% increase in DNA methylation at CpG 
site 1 (p = 0.005). In children, the same CpG site showed a negative association in relation to 
parental smoking in infancy (-0.52%, p = 0.02), although the absolute difference was small. 
At CpG site 8, both current and former smoking in the adult sample was associated with an 
increase in DNA methylation (8.74%, p = 0.042 and 6.36%, p = 0.013, respectively). Both 
CpG sites 1 and 8 reside in transcription factor (TF) binding sites for the TF Myb. In addition, 
a methylated C at CpG site 8 showed stronger TF binding in the EMSA, indicating increased 
transcription. Differential blood DNA methylation in association with active smoking has 
been observed by others. A systematic review of EWASs found 1,460 CpG sites to be 
associated with active smoking211. The most frequently reported sites were found in AHRR, 
F2RL3 and GRP15. Moreover, several studies have found associations between tobacco 
smoke exposure in utero and differential DNA methylation212-214. In a meta-analysis of 
EWAS data from 13 cohorts, maternal smoking in pregnancy associated with nearly 6,000 
differentially methylated CpGs. Persistence of DNA methylation patterns into later childhood 
was also detected124. In conclusion, several differentially methylated sites across the genome 
have been identified in relation to tobacco smoke exposure. In our study, smoking exposure 
was associated with differential methylation in the NPSR1 promoter in both adults and 
children, with the largest differences for own smoking in adults, suggesting a link between 
environmental and genetic factors. 
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Traffic air pollution has been associated with differential DNA methylation120, 215. In study II, 
we did not observe any association between NOx exposure at birth and current exposure at 8 
years, in relation to DNA methylation in the NPSR1 promoter in children from BAMSE. In 
study III, the suggestive genetic regions of importance in the association between traffic NO2 
and childhood asthma that were identified in the GWIS (ADCY2, B4GALT5, DLG2 and 
MOCOS) were also investigated for differential DNA methylation in relation to traffic NO2. 
NO2 exposure at birth showed an inverse association with DNA methylation in one CpG site 
of DLG2 (cg02275784, -2.7% per 10µg/m3 NO2 increase, p = 1.21 x 10
-4) in blood from 
BAMSE’s 8-year-olds. This CpG site is located in the gene body of DLG2 at the position of a 
predicted enhancer element. Short-term diesel exposure in adults showed inverse associations 
of DNA methylation at eight CpG sites in the DLG2 locus (-2% post- vs. pre-exposure for the 
CpG site with the lowest p = 4.64 x 10-5) and a positive association with two CpG sites (4% 
post vs. pre exposure for the CpG site with the lowest p = 1.07x10-4). In addition, decreased 
methylation was also identified at one ADCY2 CpG site, and increased methylation was seen 
at one MOCOS CpG site. 
Candidate gene studies have found differential methylation in relation to individual air 
pollution exposure in biosamples from blood216-218, nasal airway epithelium219, saliva220 and 
in buccal cells221, 222. In utero exposure to air pollution has been associated with differential 
methylation in cord blood123, 223, 224 and to global methylation in placenta225. Methylation 
changes within inflammatory genes have also been seen in mice226. A few EWASs have been 
performed in relation to air pollution exposure. A controlled experiment in adults showed 
associations between short-term diesel exhaust exposure and differential DNA methylation in 
> 2,800 CpGs in genes related to inflammation and oxidative stress141. In relation to long-
term exposure, a recent meta-analysis in more than 1,500 newborns observed associations 
between prenatal NO2 exposure and differences in DNA methylation in 3 CpGs in 
mitochondria-related genes123. In addition, differential methylation in antioxidant defense 
genes (CAT and TPO) was observed. A study using a crude comparison of children living in 
high vs. low pollution areas found differences in DNA methylation of more than 10% in 58 
CpGs227. Overall, air pollution exposure has been associated with differential DNA 
methylation across the genome. In study III, we detected associations between air pollution 
exposure in children and differential DNA methylation in DLG2, which was confirmed in a 
controlled experiment of short-term exposure in adults. 
In addition, in study II, higher methylation levels at NPSR1 CpG site 5 were seen in children 
who had a blood sample drawn in July-September (1.38%, p = 0.01) as compared with those 
who gave blood in January-March. Birth month did not affect the methylation status. In a 
study of healthy individuals, hypo-methylation in long interspersed nucleotide element-1 
(LINE-1) was seen in those who had a blood sample drawn in autumn and winter compared 
with in spring and summer, suggesting that seasonality should be taken into account in 
analyses of methylation levels228. In our analyses, adjustment for sample season did not affect 
the other results. 
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5.3 GENE EXPRESSION IN ASSOCIATION WITH GENETIC VARIANTS AND 
TRAFFIC AIR POLLUTION  
In study II, transcription factors bound differently to CpG sites in the NPSR1 promoter 
transcription start site depending on both genotype (rs2168890 at CpG site 2 and rs887020 at 
CpG site 9) and methylation status of the C allele (CpG site 2, 3 and 8). Since both disease 
status and environmental factors showed associations with differential methylation, this 
finding is of interest in terms of regulation of gene transcription. 
In study III, the SNP with the lowest p value for interaction in the look-up evaluation was 
rs686237 (interaction p = 0.0016 in CHS). This SNP is located on chromosome 20, 40 
kilobases (kb) upstream of B4GALT5 and was identified as a lung eQTL of B4GALT5 (p = 
1.18x10-17), where the C allele was associated with increased expression. eQTL analyses in 
blood from adults showed opposite direction where the C allele was associated with 
decreased expression (p = 4x10-4). Further, in BAMSE’s 16-year-olds NO2 exposure at birth 
was associated with decreased expression of B4GAL5 in blood, in homozygous carriers of the 
C allele, with a significant p value for genotype x NO2 interaction (interaction p = 0.001) 
(Figure 5.4). The ADCY2 SNPs were identified as eQTLs in blood from adults (p = 4.50x10-4 
for rs6886921), reference C allele being associated with increased expression. NO2 exposure 
at birth was positively associated with gene expression of ADCY2 in 16-yearsolds in BAMSE 
(p = 0.05), although no interaction between SNP (rs6886921) and NO2 was detected. NO2 
exposure at birth was also positively associated with gene expression of DLG2 in 16-year-
olds (p = 0.0008). 
 
    
 
Associations between air pollution exposure and gene expression profiles have been reported 
in animal models and in vitro experiments229. Few studies have been conducted in humans. In 
a comparison of children living in a highly polluted area vs. a less polluted area in the Czech 
Republic, differential genome-wide gene expression were detected in several genes, of which 
Figure 5.4 Adjusted coefficients 
and 95% confidence intervals for 
the association between NO2 
exposure at birth and peripheral 
blood gene expression levels of 
B4GALT5 at 16 years of age in 
BAMSE, stratified by rs686237 
genotype. The coefficient is the 
log-fold change in gene 
expression per 10µg/m3 increase 
in NO2 exposure. 
Interaction p value = 0.001 
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C15orf16 and DUSP15 showed the lowest p values for differential expression (p = 4.97x10-7 
and 2.59x10-6, respectively)230. Short-term exposure has been associated with changes in gene 
expression in genes related to inflammation, tissue growth and environmental defense 
mechanisms including oxidative stress231-233 as well as protein degradation and 
coagulation234. To conclude, SNPs identified in the GWIS screening step showed significant 
eQTL effects in relevant tissues. Few studies on air pollution exposure in relation to gene 
expression have been performed, although evidence suggest that exposure is associated with 
differential expression of certain genes. In study III, the top hit replicating SNP in the 
B4GALT5 locus provided supportive evidence for interaction with air pollution in relation to 
gene expression.  
 
5.4 METHODOLOGICAL CONSIDERATIONS 
This thesis is based on the well-characterized prospective birth cohort BAMSE as well as 
other similar birth cohorts with large number of participants, high retention rates within the 
cohorts, repeated assessments of health outcomes and exposures with reasonably good 
overlap in outcome and exposure definitions. A strength is the uniform outcome definitions 
obtained from detailed questionnaires repeatedly filled out during childhood, as well as 
objective measurements of sensitization. For a large proportion of children, SNPs were 
previously genotyped, using candidate gene and genome-wide approaches, and some of the 
children from BAMSE had DNA methylation and transcriptomic data available, which gave 
the possibility to study GxE at genetic, epigenetic and transcriptomic levels. Collaboration 
with other research groups, as well as the availability of comprehensive online resources, 
enabled functional follow-up analyses. However, both epidemiological and experimental 
studies are subject to limitations, related to study design or methods used, that should be 
taken into consideration when interpreting the results of these studies. 
5.4.1 Random errors 
In epidemiological studies, a sample of the population is studied. This sample will only give 
an estimate of the true population characteristics. Due to variability in the population, a 
randomly selected sample can introduce random errors. The precision will increase with 
increasing sample size. Confidence intervals are presented as an indicator of precision, where 
narrow confidence intervals represent higher precision. The precision of a study can also be 
affected by the prevalence of exposure and outcome or the quality of measurements. The 
precision of a study hence largely depends on random errors. 
Studies I, II and III included subsamples of the original cohorts with adequate blood samples, 
informed consent and questionnaire data available, which to some extent limited the sample 
size. Studying GxE further reduced the sample size, since only a limited number of cases and 
controls had the combination of variables under study available. To enable observation of 
small effects of risk alleles an even larger sample size would have been preferred.  
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To increase the sample sizes, studies I and III were based on international consortia using 
meta-analysis and look-up approaches, resulting in analyses of 14,595 and 1,534 plus 1,602 
children, respectively. The confidence intervals were rather narrow for study I, indicating 
good precision. In studies II and III, smaller sample sizes were available, which introduced 
some statistical uncertainty. Study IV included 2,359 children from the BAMSE cohort and 
the confidence intervals were rather narrow. However, the power for analysis of GxE in study 
IV was limited, due to the small sample size with genetic information available.  
5.4.2 Systematic errors 
Systematic errors, or bias, are errors that cannot be reduced by increasing the sample size. 
Systematic errors are related to the enrolment of study population, the assessment and 
definition of exposures and outcomes. Absence of systematic errors means high validity of a 
study. In epidemiology, systematic errors are usually divided into three categories: selection 
bias, information bias and confounding. 
5.4.2.1 Selection bias 
Selection bias will be present if the association between exposure and disease differs between 
subjects included and those not included in the study127. In prospective cohorts, subjects are 
typically enrolled before the outcome has occurred and therefore selection bias is unlikely. 
Loss to follow-up may introduce selection bias. In BAMSE the participation rate has been 
high over time with a response rate of 84% for the questionnaire at 8 years and 78% at 16 
years, with 60% and 63% participating in the clinical examinations at 8 and 16 years, 
respectively. The distribution of baseline characteristics, including parental allergy, were 
similar between the original cohort and the follow-ups, including the clinical examinations.  
The inclusion criteria for each study are also subject to possible difficulties in obtaining a 
large enough and representative sample. The main analyses in studies I-III were dependent on 
which children participated in the clinical examinations, and gave blood and informed 
consent for genetic analyses. From the available samples, cases and a random selection of 
controls were selected for gene-specific and genome-wide genotyping.  
5.4.2.2 Exposure assessment and outcome definitions in epidemiological studies 
Information bias, or misclassification of exposure or outcome, can be either differential, 
meaning that the exposure or outcome depends on the other variable, or non-differential, if it 
does not depend on the other variable128. In BAMSE, differential misclassification of 
exposure is unlikely, thanks to the prospective study design where the exposure was assessed 
before the outcome occurred. However, parental heredity and allergic disease in early life 
might modify exposures later in life. Adjustment or restriction could control for that.  
Mold, air pollution and food are complex mixtures of exposures where the exact disease-
causative agents are not known. Assessment across cohorts may include analyses of 
heterogeneous variables, especially when combining data from different study areas and 
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countries. The choice of assessment method is critical and validation of the methods is 
important.  
Visible mold will not necessarily be aerosolized and inhaled and there is a complex mixture 
of microbial agents and components in indoor environments235. In our study, exposure was 
assessed from parental responses to questionnaires, meaning that we could not elucidate the 
microbial content of the mold. Exposure assessment was performed in early life; however, 
bias might exist with over-reporting of exposure in children with symptoms of early wheeze 
or in families with parental allergic disease236, which could lead to an overestimation of the 
associations between mold and outcomes in early life. In a recent study in BAMSE, risk 
estimates for asthma and rhinitis in relation to mold exposure were elevated among children 
both with and without parental allergic disease172. Also, over-reporting of dampness and mold 
in self-reported vs. inspectors reported observations has not been observed in relation to 
respiratory illnesses37, 40. 
Air pollution estimates have been modeled. In modelling, there is a fine balance between the 
incorporation of accessible predictors and adding too much uncertainty to the model. 
Validation studies have shown that both dispersion146, 237, 238 and LUR estimations239, 240 
correlate well with outdoor measures. Outdoor levels modelled with dispersion modelling 
have shown good agreement with personal exposure measurement241. Good agreement was 
also seen between LUR and dispersion modelling for NO2 estimates with a correlation of > 
0.86, for areas included in study III242.  
Exposure to air pollutants was only estimated at residential and school addresses, whereas 
personal exposure and indoor exposure were not accounted for in the model. Since air 
pollution estimates were produced independently from the outcome assessments, any bias 
related to traffic air pollution exposure is assumed to be non-differential, possibly with 
attenuation of the true associations.  
Smoking was assessed through questionnaires, with a possibility of underreporting. The 
association with methylation is assumed to be non-differential. 
The FFQ used in study IV has not been validated in children, although the BAMSE study 
used a similar FFQ as a cohort of Swedish women. In this adult population, the validity and 
reproducibility of the FFQ-based TAC estimates have been assessed and a correlation of 0.27 
(95% CI 0.06-0.46) was observed between lipophilic and whole plasma ORAC and FFQ-
based ORAC estimates243. However, with respect to true exposure levels, TAC in plasma 
may not be the gold standard to estimate antioxidant intake, as both endogenous and 
exogenous factors besides dietary intake can affect TAC levels in plasma. FFQs may cause 
bias, since responders could find it hard to remember what and how much of each specified 
food item that was eaten during the previous 12 months. Further, individual eating habits 
could violate the estimation. Questionnaire data on 98 food and drink items were available in 
study IV. ORAC-TAC values from the US database were available for only 35 of these, 
although the major sources of antioxidant-rich foods were covered by both our FFQ and the 
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US database. The remaining 63 items in our FFQ with no TAC data available were dairy 
products, margarine or oils, meat dishes, fish, egg, pasta, rice, pizza, sweets or snacks, foods 
known to have low content of antioxidants in general. There might be differences in the 
antioxidant content related to different growing conditions and cooking methods of the foods 
consumed in our Swedish cohort in comparison to the foods in the US database, which could 
introduce errors in our TAC estimates. Still, we considered the TAC values to be valid in the 
BAMSE cohort of Swedish children and potential misclassifications are believed to be non-
differential. 
Misclassification of the outcomes is possible when the information is ascertained by parental 
questionnaires. Asthma or allergic symptoms might be reported more often among parents 
with allergic disease themselves due to a higher awareness of the disease. Early wheezing 
could be mistaken for airway infections and younger children have less distinctive asthma 
symptoms making it harder to diagnose true asthma. The disease definitions used in the meta-
analyses have been harmonized and used in several international collaborations before54, 106, 
244. In studies II and III, all children with a doctor’s diagnosis of asthma ever, up to 8 years of 
age, were defined as cases. This broad definition enabled inclusion of many subjects, 
although with the potential limitation of a reduced contrast between cases and controls. For 
the asthmatics included in studies II and III, 49% had a current diagnosis at age 8 years, 
whereas 23% only had a diagnosis at 1 or 2 years of age in study II and, for study III, 26% 
were diagnosed at 1 or 2 years of age only. Sensitization was assessed using standardized 
methods. The IgE concentration in blood was measured for most cohorts, whereas ALSPAC 
and CAPPS used SPT to assess sensitization status. 
5.4.2.3 Confounding in epidemiological studies 
A confounder must be associated with both the disease and the exposure, and must not be an 
effect of the exposure128. If a confounder is not controlled for in the analysis, an observed 
association may in fact be due to the confounding factor. Confounding can cause either 
underestimation or overestimation of effects. It could also be strong enough to reverse the 
apparent direction of effect128. In my studies, adjustments were made for known or suspected 
confounders for asthma and allergic disease as well as for variables influencing the effect 
estimates. 
Dampness and mold may be particularly prevalent in poorly maintained housing and may 
additionally contribute to poor health in populations who are already living with an increased 
burden of disease34. However, socioeconomic status was not a confounder in the association 
between mold and asthma or allergic disease and was therefore not adjusted for in study I173. 
Since the fungal profile could differ between different homes and different study areas, 
residual confounding cannot be excluded for this exposure. For most cities, low 
socioeconomic status is related to living in highly polluted areas. In Stockholm, the opposite 
is true. Children from families with high socioeconomic status tend to live in the inner city, 
where the levels of air pollution are highest. Therefore, all analyses of traffic air pollution 
estimates were adjusted for municipality. 
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We did not have information about maternal diet in pregnancy or early life dietary TAC 
estimates (study IV). Further, any potential bias related to an unhealthy diet cannot be ruled 
out, since a high dietary TAC might just reflect the relative intake of protective and harmful 
foods that influence the pro-oxidant-antioxidant balance245. However, adjustment for meat 
intake did not affect the obtained estimates.  
Disease-related modification of consumption is a methodological challenge when studying 
diet, mainly in cross-sectional studies, but also to some extent in longitudinal studies. 
Children who reported allergic symptoms related to fruits and vegetables, and/or who 
avoided these because of allergic symptoms, were significantly more represented in the 
lowest tertile of TAC intake. After exclusion of children who avoided fruits or vegetables due 
to allergic symptoms, the results remained comparable for the association between dietary 
TAC and sensitization to inhalant allergens. Since TAC aims to reflect the whole diet, it may 
be less affected by disease-related modification of consumption affecting single food items, 
as reported by Rosenlund et.al73. Indeed the sensitivity analysis showed no evidence of 
disease-related modification. 
Residual confounding cannot be ruled out because of unmeasured confounding or 
measurement errors in confounders already adjusted for and this applies to all studies in this 
thesis. 
5.4.2.4 Assessment of genetic, epigenetic and transcriptomic data 
Genotyping errors cannot be excluded, although these are believed to be non-differential. 
Whole genome microarrays may in fact not cover the whole genome. Despite of imputation 
(from HapMap2 data) of SNPs in the genome-wide analyses, which resulted in about 2.5 
million SNPs, a denser genomic coverage, through 1000 Genomes imputation might have 
reduced the risk of false negative findings in study III. At the time when our GWIS study was 
initiated, only HapMap2-imputed data were available for all cohorts. However, 1000 
Genomes data was available for BAMSE and a comparison between HapMap2 and 1000 
Genomes results for two of the top hits (B4GALT5 and ADCY2) did not identify any other 
SNP that was not already in high LD with the already identified SNPs. Only common 
variants, with a minor allele frequency > 5% were investigated. To cover rare variants next-
generation sequencing technologies would be preferred246. 
We observed rather small absolute differences in methylation levels in relation to exposures 
and outcomes investigated (studies II and III). It should be noted that methylation differences 
may involve technical variation related to the bisulfite treatment, EpiTYPER or Illumina 
450K microarray chip, and adjustment for batch effects is therefore often applied. 
Unsuccessful conversion of an unmethylated cytosine to a thymine may cause false positive 
findings247, which should be random with respect to the exposure of interest, leading to non-
differential misclassification. The Illumina 450K microarray covers CpG sites distributed 
over the genome, including CpG islands, CpG island shores, shelves, promoters, gene bodies 
and intergenic regions; still it only includes about 2% of the total number of CpG sites. In 
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study III, functional follow-up of CpG sites 50 kb up- or downstream of the identified genes 
were investigated in relation to air pollution exposures and regions of 250 kb up- or 
downstream of the SNP were investigated for gene expression. There is no consensus on the 
optimal distance for these types of analyses, though strongest associations between SNPs and 
CpG sites have been detected for SNPs located close to the CpG sites, within 500kb248. 
Regarding genome cover in the transcriptomics analyses, the Affymetix HTA 2.0 microarray 
includes both coding and non-coding transcripts covering all known genes and transcript 
isoforms. 
5.4.2.5 Confounding in genetic studies 
Genotypes are known to differ between ethnic groups, and ethnicity was adjusted for in 
analyses of genotypes by restriction (to e.g. Caucasians) or adjustment. A SNP can affect 
methylation, if it coincides with a CpG site or by being a methQTL. In study II, analyses 
were restricted to homozygous carriers of a SNP creating a CpG site. In study III, CpG site 
SNPs were excluded. For both studies II and III, methylation and transcriptomic samples 
were randomized into batches and batch effect was adjusted for.  
Tissue specificity and cell type adjustment 
Methylation and gene expression patterns can be tissue-specific. To look for differential 
methylation and gene expression in relation to respiratory and allergic diseases, lung and 
blood tissue would be of relevance to study. Furthermore, specific types of lung tissue, e.g., 
epithelial or alveolar cells, might show different direction of effects. Bronchial epithelium is 
the first contact with cellular responses for environmental exposures such as air pollution. 
Samples are most commonly extracted from peripheral blood for reasons of convenience, and 
its relevance is supported by the systemic nature of allergy and to some extent, asthma.  
Without cell type adjustment, confounding by, e.g., difference in cell type composition 
between cases and controls can be present. Cell separation or adjustment for cell type is 
therefore of importance in the assessment of DNA methylation and gene expression. In study 
II, no cell type correction was performed, which potentially could have biased our results. 
However, whole blood and cell-sorted blood from six healthy males suggested constant 
methylation levels across cell types in the NPSR1 gene, indicating that whole blood was a 
reliable source for DNA methylation analysis. In study III, cell type correction was done 
using the Houseman algorithm167 in combination with reference data from the 
aforementioned cell-sorted blood117. Measured cell counts were adjusted for in the 
transcriptomic data.  
Stability over time 
DNA methylation and gene transcription are dynamic processes influenced by numerous 
factors such as genetic variants, age, exposure and health conditions125. Assessed levels may 
depend on timing of sampling (as seen in study II, where season of blood sampling was 
associated with differential DNA methylation) and stability of DNA methylations may 
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depend on the genomic locations of the CpG sites. At a population level, maternal smoking 
during pregnancy as well as air pollution exposure during pregnancy have been associated 
with differential methylation in cord blood with persistence of DNA methylation patterns into 
later childhood123, 124. However, since DNA methylation and gene expression was assessed at 
one point in time (studies II and III), these analyses should be considered to be cross-
sectional. The assessed levels may not represent long-term effects in our studied material and 
the direction of effect cannot be ruled out.  
Even if we can assume that the associations seen in our studies are true, and not explained by 
residual or unmeasured confounding, it may still not be possible to draw conclusions about 
causality. The identified disease-associated SNP might not be the SNP that is truly associated 
with disease. It can be in LD with a SNP in another locus that causes the effect and there 
might be several mediating steps in between, e.g., DNA methylation, gene expression, protein 
expression or further interactions with other loci. Therefore, the identified disease-associated 
loci from the GWIS were further investigated in functional follow-ups. 
5.4.3 Generalizability of results  
The birth cohorts included in studies I-III are population-based. For BAMSE, 75% of those 
eligible were included in the final cohort. Parental smoking was more common among non-
participants, whereas allergic heredity and other factors did not have an impact on 
participation. The cohort was therefore considered reasonably representative for the general 
population of the same age, although not fully representative regarding smoking exposure129. 
The objective of studies I-III was to gain knowledge in the underlying mechanisms of allergic 
disease. If equal underlying biological mechanisms can be assumed, the observed 
associations could be generalizable to most populations of European and non-Hispanic white 
origin. 
Our results in study IV could be considered generalizable to a Swedish population of 
children, since the study population represented the original population-based BAMSE 
cohort, with respect to baseline characteristics. Generalizability to most populations could be 
assumed, given the belief of equal underlying mechanisms. 
 
5.5 STUDYING INTERACTIONS BETWEEN GENES AND ENVIRONMENT  
5.5.1 Statistical models 
Different approaches were used to study interactions in this thesis. Traditional models for 
evaluating interaction were applied in studies I, III and IV by investigating statistical 
interaction on a multiplicative scale. To enable interpretation of statistically significant 
interactions (often presented as a significant p value for interaction), stratifications are 
commonly performed. This was done in studies I, III and IV to visualize the strength of 
association and the precision (by presentation of confidence intervals). In study I, the minor 
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allele frequency (MAF) was 12%, whereas MAF ranged between 9% and 35% for the top hit 
SNPs in study III. Dominant coding of SNPs was tested in all studies in order to increase 
power. 
Traditional interaction models have been shown to be appropriate for targeted and 
hypothesis-driven analyses. Assessment of interactions in a hypothesis-free manner, as in 
GWIS, demands very large sample size and power easily becomes a concern. Different 
GWIS approaches have been subject to much attention in the past years249-252 given that GxE 
effects have been very challenging to identify. 
In our GWIS (study III), a sufficient sample size was definitely a concern. Power 
improvement was addressed by performing meta-analysis, and using two alternative 
statistical approaches, the 2 df test112 and the two-step approach113. The 2 df test was 
constructed to detect main genetic effect in either exposed or unexposed subjects and to 
detect main effects while taking the environmental exposure fully into account, although it 
was not optimized to primarily detect interaction effects. The two-step approach (see section 
4.7.1) was used in order to identify loci of relevance for NO2 interaction, utilizing a low 
significance threshold with no penalty of multiple testing correction. The much lower number 
of SNPs that passed the first step was then evaluated for interaction using logistic regression. 
Since fewer SNPs had to be adjusted for multiple testing, the power was increased. Even if 
we found genome-wide interaction effects in the discovery dataset using the two-step 
approach (MAGI1 SNPs), these SNPs did not replicate in CHS or CAPPS/SAGE. In our case, 
the standard interaction model provided candidates (ADCY2, B4GALT5, and DLG2) that were 
eventually supported by functional analyses. 
While the application of new methods to detect gene-environment effects (e.g., the 2 df test 
or the two-step approach) is one way to overcome power challenges, we believe that gene-
environment effects should be evaluated also at the epigenetic and transcriptomic levels to 
functionally support GWIS top hit findings. 
5.5.2 The role of functional studies and bioinformatics resources 
Upon identification of GxE effects, a next step would be to understand the functional 
relevance of this interaction. Identified SNPs are often located outside the protein-coding 
regions operating as regulatory SNPs with unknown functional consequences253, and are 
usually part of a larger region of correlated variants (in strong LD). Both SNPs and 
environmental exposures could affect methylation and gene expression, and DNA 
methylation could regulate gene expression254. Therefore, a GWIS can be seen as a screening 
tool to identify genetic loci that may interact with the other variables under study. 
DNA methylation has been suggested to be involved in mediating GxE effects, and several 
examples exist in the literature related to air pollution exposure120, 215. In studies II and III, we 
investigated whether environmental exposures influenced the methylation levels of CpG sites 
in the asthma candidate gene NPSR1 and CpG sites in asthma-associated loci identified in the 
GWIS. We found that smoking and air pollution exposure were both associated with 
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differential methylation in peripheral blood cells of the investigated regions, indicating a link 
between environmental and genetic factors. Further, study III investigated suggestive GxE 
effects at the transcriptomic level. SNP main effect on gene expression was observed as well 
as association between NO2 exposure on gene expression, with significant interaction for 
genotype. 
Thanks to public repositories and available datasets through different collaborations, look-up 
of research findings was possible in different tissues, allowing for DNA methylation and gene 
expression analyses in study III. Further, GxE could also influence the expression of proteins 
encoded by the genetic variant. Protein expression data was not available in the BAMSE 
material obstructing analyses of differential expression. However, results from the Human 
Protein Atlas showed that the identified genes were expressed at protein levels in normal 
respiratory tissue and smooth muscle tissue145. 
 
5.6 REPLICATION OF GENE-ENVIRONMENT INTERACTIONS 
Despite a large sample size in study I, interaction with the GSTP1 genotype could neither be 
confirmed nor ruled out. This highlights the complexity of studying interactions involving 
genes in a multifaceted oxidative stress defense system. Several studies on air pollution in 
relation to childhood asthma81, 83, 84, 255 as well as lung function85 have shown evidence for 
interaction with GSTP1 and TNF genotypes, although with different direction of effects. 
These candidate genes were initially identified as having a main effect on asthma and allergic 
disease, which might explain observed heterogeneity in interaction analyses. 
In our GWIS, a meta-analysis was performed including, at that point in time, all available 
cohorts with information on childhood asthma, NO2 exposure estimates and GWAS data; 
totaling 454 asthmatics and 1,080 never-asthmatics. Although promising loci were identified, 
we did not reach genome-wide significance for the interaction analyses. Likewise, many 
previous GWIS efforts to detect GxE effects for respiratory disease and lung function have 
failed in reaching genome-significant interaction p values, in studies with a sample size of 
20,000187 or even up to 50,000 subjects186. Thus, new loci have been challenging to discover 
using standard interaction analyses with stringent genome-wide significance demands, even 
in well-powered studies. In addition, well-studied candidate genes for GxE have been 
difficult to replicate using GWAS data185.  
Research in large-scale consortia demands good quality data with harmonization of variables 
over participating study centers. The difficulties in replicating findings may relate to different 
environments (with respect to exposure levels or constituents) or populations (including 
different allele frequencies). The effect of genotype and environment might influence the 
phenotype differently in different populations or environments, which could be related to co-
exposures or unmeasured confounding. Meta-analysis may therefore not necessarily increase 
the power because of heterogeneity in study design. However, allele imputation, adjustment 
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for population stratification and using harmonized exposure and outcome definitions can 
meet some of these uncertainties.  
In study I, the prevalence of mold exposure varied between 27% and 68% between cohorts, 
which could possibly be explained by different climate or housing conditions, a heterogeneity 
that may have affected the power to identify interaction. Similarly, in study III, the range of 
estimated air pollution levels varied between cohorts in the discovery meta-analysis, where 
BAMSE had lower exposure levels than the other two cohorts (Figure 5.5). 
 
 
Sensitivity analysis with exclusion of BAMSE from the meta-analysis showed same 
magnitude and direction of interaction beta values for BAMSE as for meta-analysis of 
GINI/LISA and PIAMA cohorts. This indicated that the difference in exposure levels did not 
influence the discovery results to any major extent. Stringent meta-analysis of the top hit 
SNPs between the European and North American cohorts was not performed due to 
heterogeneity in study designs. Air pollution data from CHS was assessed using a different 
method and the exposure was obtained for when children were 8 years of age. 
SNPs that have shown genome-wide significance for main effects in GWASs, such as the 
ORMDL3 and GSDMB loci, have been analyzed in many studies and for different ethnicities, 
with results indicating true associations with asthma. SNPs with a lower effect estimate may 
be difficult to identify in low-powered studies. In genome-wide studies, multiple testing 
correction is necessary to avoid false positive findings, with the penalty of increasing the 
likelihood of false negatives. Less significant SNPs from GWASs may still be of importance 
in the disease mechanism and should not be discarded from further study. Our approach was 
therefore to perform functional analyses of all the top GWIS findings that also showed 
significant interaction in the look-up data set, to further look for evidence of their 
involvement in childhood asthma at a more detailed level.  
New genetic findings were revealed in the GWIS when we looked at interactions followed by 
methylation and gene expression associations, which were verified in different tissues. 
Consistent epigenetic effects surviving multiple test corrections in adults and children for one 
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Figure 5.5 Range of NO2 exposure levels 
(min-max) for the cohorts included in the 
discovery meta-analysis. Boxes represents 
5th to 95th percentiles and median. Black 
diamonds indicates mean exposure levels. 
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of the genes (DLG2) using both experimental and epidemiologic data, speak for a solid 
finding. 
It should be noted that the SNP with the lowest p value in the look-up evaluation, rs686237 
on chromosome 20, showed a rather complex interplay with exposure and asthma risk. First, 
the direction of interaction effect differed between the discovery meta-analysis and the 
primary look-up dataset. We observed that AC/AA carriers had the highest risk of asthma 
following NO2 exposure in the discovery datasets (OR 1.69 95% CI 1.08-2.64), whereas CC 
carriers had the highest risk in CHS (OR 1.21 95% CI 1.04-1.41). Detailed analyses in CHS 
revealed strong confounding effects in the data set, and the differences in asthma risk might 
be influenced by residual confounding. Rs686237 was found to be a strong eQTL for 
expression of B4GALT5 in the lung and was further identified as an eQTL in whole blood. In 
lung tissue, the C allele was strongly associated with increased expression (risk allele in 
CHS), but in blood (GTEx), the opposite pattern was observed, with the A allele being clearly 
associated with increased expression (risk allele in the discovery datasets). Stratified analyses 
by genotype in BAMSE (blood) confirmed the GTEx findings in that allele A carriers 
displayed increased B4GALT5 expression following NO2 exposure, but allele C carriers 
displayed decreased expression.  
In summary, the GWIS study support the notion that GxE effects are important in the 
pathogenesis of asthma. Although our findings showed a complex interplay, the study 
highlights the importance of studying GxE at different levels by analyzing genetic variations, 
gene regulation and gene expression to understand disease pathophysiology. Since the role of 
these genes and genotypes in the pathogenesis of asthma is not known, further studies are 
warranted.  
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6 CONCLUSIONS 
Based on the studies in this thesis, the following conclusions can be drawn: 
I: Early mold exposure was associated with early wheezing and nasal symptoms in children. 
Modification by a functional genotype in the GSTP1 gene, involved in the anti-oxidative 
stress system, could not be confirmed. 
II: NPSR1, a gene identified for susceptibility to asthma, showed differential DNA 
methylation in the promoter region in relation to adult and childhood asthma, in particular 
childhood allergic asthma. Environmental exposures, such as smoking and season of blood 
sampling, were also associated with differences in DNA methylation levels. 
III: Using a genome-wide approach we found that interactions between single nucleotide 
polymorphisms and traffic air pollution exposure are likely to be important for asthma 
development. DNA methylation and gene expression analyses provided supportive evidence 
for interaction with air pollution for ADCY2, B4GALT5 and DLG2. 
IV: An antioxidant-rich diet in childhood may protect against development of allergic 
sensitization to inhalant allergens. Our results indicated that the beneficial effect was 
predominant in conditions of low oxidative stress, e.g., exposure to low levels of air 
pollution.  
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7 FUTURE PERSPECTIVES 
Evidence today suggests that a combination of genes and environment plays a crucial role in 
asthma and allergic disease development. The results in this thesis imply that genetic variants 
could influence associations between environmental exposures and asthma and allergic 
disease. Further, interaction between environmental factors was indicated in relation to 
disease development.  
Studying GxE interactions in asthma and allergic disease is a challenge with respect to study 
power, especially at the genome-wide level. Adequate sample size, high quality data with 
detailed genotyping and exposure assessments, as well as deep phenotyping (possibly with 
the help of objective biomarkers) are important factors to increase study power. The use of 
international collaborations and consortium data can contribute with enlarged sample sizes to 
investigate different sub-phenotypes with sufficient power, although harmonization of data is 
a delicate issue and it is important to put efforts into harmonizing the variables between 
studies. Collaborations and publicly available databases, which have already become 
commonly used in genetic studies, can provide opportunities for look-up of research findings 
in other settings. 
There is a need for improved statistical methods and ways to follow up GxE findings with 
functional studies. Future research should focus on studying more complex interaction 
patterns, such as interactions between several genetic variants at once or analyzing haplotype 
structures. The integration of different omics data raises a need for method development on 
how to handle the amount and complexity of information obtained from simultaneous 
analysis of genome-wide genetic-, epigenetic-, transcriptomics-, proteomics- and 
metabolomics- data. 
The results in this thesis indicated a possible link between environmental exposures and 
epigenetic as well as transcriptomic events, which should be further investigated in 
longitudinal set ups. Relevant tissues and cell types (e.g., airway epithelium) should be 
studied in relation to methylation and gene expression in a longitudinal manner, in order to 
get one step closer to deciphering causality and investigating the stability of changes over 
time. In particular, looking at changes over time in relation to exposure, or before and after 
disease onset, in the same individual could provide new insights into disease mechanisms. 
Through increased understanding of these patterns, there is potential for developing new 
diagnostic tools. 
Pregnancy cohorts that can consider in utero exposures would be preferred, or multi-
generation studies, with longitudinal bio-sampling of blood and other relevant tissues. 
Follow-up of these individuals up to adulthood would enable investigation of early risk 
factors for later development of asthma related lung diseases such as COPD.  
  55 
8 POPULÄRVETENSKAPLIG SAMMANFATTNING 
Astma, hösnuva och eksem är exempel på allergisjukdomar. Förekomsten av 
allergisjukdomar hos barn är stor. Många barn i Sverige kommer att ha någon form av 
allergisjukdom under sin uppväxt och astma är den vanligaste kroniska sjukdomen hos barn. 
Den största riskfaktorn för allergisjukdom är ärftlighet, men under de senaste decennierna har 
sjukdomsförekomsten ökat, vilket tros beror på förändringar i den omgivande miljön. 
Föräldrars rökning, mögel i bostaden, trafikrelaterade luftföroreningar, kost och kontakten 
med mikroorganismer är exempel på miljöfaktorer som har kopplats samman med 
allergisjukdomar hos barn. I dagsläget vet man inte exakt vilka mekanismer som ligger 
bakom sjukdomsutvecklingen men arv och miljö tycks samspela. 
Syftet med den här avhandlingen var att studera genetiska faktorers inverkan på sambanden 
mellan miljöfaktorer och allergisjukdom. Avhandlingen omfattar fyra delstudier vilka alla 
inkluderar epidemiologiska data från den svenska födelsekohorten BAMSE, en studie på 
4000 barn i Stockholmsområdet som följts upp till 16 års ålder. Delarbete I och III inkluderar 
också data från liknande födelsekohorter i Europa och Nordamerika. Delarbete II innefattar, 
förutom BAMSE, en kohort på vuxna med kronisk luftvägssjukdom. Information från 
experimentella studier och från publika databaser har också nyttjats. 
I delarbete I undersöktes sambanden mellan tidig exponering för fukt och mögel i bostaden 
och allergisjukdomar upp till skolåldern, samt inverkan av genen GSTP1. GSTP1 kodar för 
ett enzym som finns i lungan och som kan hjälpa till i kroppens försvar mot toxiska 
substanser som inandats. Naturligt förekommande varianter av GSTP1 kan göra vissa 
individer mer känsliga än andra för exponering av inandningsbara substanser. Studien 
inkluderade totalt 14 495 barn, och innefattade BAMSE-studien samt fem andra 
födelsekohorter. Exponering för fukt och mögel var relaterat till tidig väsande andning 
(”wheeze”) samt hösnuva upp till skolåldern. Den ökade risken för hösnuva sågs främst hos 
barn som hade en viss variant av GSTP1. Sammanfattningsvis indikerade resultaten att 
exponering för fukt och mögel i hemmet under de två första levnadsåren var kopplat till 
allergisjukdom hos barn, en påverkan som främst sågs hos barn som hade en viss genetisk 
variation. 
I delarbete II studerades den tidigare identifierade astmagenen NPSR1. Epigenetiska 
förändringar, det vill säga kemiska förändringar av vår arvsmassa som kan påverka genernas 
uttryck och funktion, har föreslagits vara kopplingen mellan miljöexponering och sjukdomar 
som astma. I detta delarbete undersöktes om miljöexponeringar och astma var kopplade till 
sådana epigenetiska förändringar i NPSR1. I studien sågs samband mellan epigenetiska 
förändringar i relation till astma hos både vuxna och barn, och speciellt i relation till allergisk 
astma hos barn. Hos vuxna rökare identifierades också epigenetiska förändringar, vilka inte 
sågs i samma utsträckning hos icke-rökare. Epigenetiska skillnader sågs också beroende på 
vilken tid på året blodprovet togs. Resultaten från denna studie tyder på att det finns samband 
mellan miljöexponering och epigenetiska förändringar, vilka i sin tur föreslås påverka 
reglering av geners uttryck. 
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Syftet med delarbete III var att studera hela arvsmassan för att identifiera barns känslighet 
för trafikrelaterade luftföroreningar och risken att utveckla astma. Studien inkluderade mer än 
3 300 barn från tre Europeiska och två Nordamerikanska kohorter. Exponering för förhöjda 
halter av luftföroreningar under första levnadsåret var kopplat till astma, men bara hos barn 
som hade ett visst genetiskt arv. Två av de gener som identifierades, ADCY2 och DLG2, har i 
tidigare studier kopplats till lungfunktion och lungsjukdomen KOL. Uppföljande studier 
gjordes för att studera genreglering och genaktivering i blod och lungvävnad. 
Luftföroreningsexponering kunde kopplas till epigenetiska förändringar i DLG2, vilket 
studerades hos barn från BAMSE-studien samt hos vuxna individer som utsatts för 
dieselavgaser i exponeringskammare under kontrollerade former. En av de identifierade 
genetiska variationerna (rs686237) visade sig påverka uttrycket av en närliggande gen, 
B4GALT5. Detta testades i lungvävnad hos vuxna individer. Hos barnen i BAMSE-studien 
sågs också en koppling mellan luftföroreningsexponering och uttryck av B4GALT5 i blod, 
och detta samband påverkades i sin tur av vilken variant av rs686237 som barnet hade. 
Sammantaget visade resultaten att barn med ett visst genetiskt arv påverkar deras känslighet 
för luftföroreningar och utveckling av astma. Studien lyfter fram betydelsen av att studera arv 
och miljö på flera nivåer genom att analysera genvariationer, reglering och genuttryck för att 
identifiera sjukdomsmekanismer. 
I delarbete IV undersöktes huruvida en kost rik på antioxidanter i 8-års åldern påverkade 
nyinsjuknandet i astma, hösnuva eller sensibilisering mot luftburna allergen vid 16 års ålder. 
Flera av barnen undvek intag av vissa frukter eller grönsaker på grund av allergiska symptom 
mot dessa, vilket kan påverka de studerade sambanden mellan kostens potentiellt skyddande 
effekt i förhållande till allergisjukdom. Tidigare studier som undersökt effekterna av ett högt 
antioxidantintag har visat tvetydiga resultat. Många studier har heller inte tagit hänsyn till 
denna sjukdomsrelaterade påverkan på kostintaget. Resultaten från delarbete IV visade att de 
barn som hade ett högt intag av antioxidanter via kosten hade en minskad risk för 
sensibilisering. Effekten kvarstod efter att vi tog hänsyn till sjukdomsrelaterad påverkan av 
kostintaget. Vidare kunde den gynnsamma effekten av antioxidanter bara identifieras hos de 
barn som levde i områden med lägre halter av luftföroreningar. Genetiska variationer i två 
gener kopplade till antioxidativa mekanismer (GSTP1) och inflammation (TNF) påverkade 
inte de studerade associationerna. 
Sammanfattningsvis tyder resultaten i denna avhandling på att genetiska variationer påverkar 
sambanden mellan miljöexponeringar, såsom fukt och mögel samt luftföroreningar, och 
astma och allergisjukdomar hos barn. Samverkan mellan miljöfaktorer verkar också kunna 
påverka utvecklingen av allergisjukdom. Det verkar också finnas samband mellan 
miljöexponeringar och epigenetiska förändringar såväl som geners uttryck. 
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Hanna, Mariann, Niosha, Sofia W.L och Sofia A.W. Alla små och stora i Lillens Sällskap, 
bästa grannarna ever. Sofi och Jo, tack för arbetsron. Alla fina klättrare (och ni andra som 
hör därtill) som delar mitt intresse för problemlösning. Mamma och pappa, för att ni är så 
kloka och okomplicerade. Tack för bra gener och en utmärkt uppväxtmiljö. Staffan, för att 
jag fått äran att vara lillasyster till den snällaste storebror man kan önska sig. Kära Anne, tack 
för att du tar så bra hand om oss allihop! Jämt. Oavsett. Bosse, tack för att du alltid varit mån 
om att jag ska ha ett bra arbetsklimat. Minna och Hannes, tack för allt mysigt häng och alla 
roliga äventyr. Jag ser fram emot den långa fortsättningen. 
Andreas, du vet hur mycket du betyder för mig. Tack för att du inspirerar mig till att tänka 
lite djupare och klättra lite högre. Teodor och Mira, de finaste personerna i världen. Jag 
älskar er, mest av allt.
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